Charles C. Guo, M.D.

Peer-Reviewed Articles

1. Mi, W, Zang, C, Zhao, J, Kamat, A, Wei, P, Hansel, DE, Czerniak, BA, Guo, CC. Mixed-grade papillary urothelial carcinoma with a minor high-grade component shows a significantly worse clinical outcome than low-grade papillary urothelial carcinoma. Human Pathology 163, 2025. e-Pub 2025. PMID: 40780614.
2. Downes MR, Lopez-Beltran A, Contieri R, Hansel DE, Paner GP, Shen S, van Rhijn BWG, Al-Ahmadie H, Amin MB, Brunelli M, Comperat E, Cookson MS, Faltas BM, Guo CC, Hartmann A, Kamat AM, Mertens LS, Ross JS, van der Kwast TH, Warrick J, Kristiansen G, Cheng L, Raspollini MR. International Society of Urological Pathology Consensus Meeting 2024: Working Group 2 Preneoplastic and Precursor Lesions of the Urinary Bladder. Am J Surg Pathol, 2025. e-Pub 2025. PMID: 40590266.
3. Reis H, Al-Ahmadie H, Gaisa NT, Lopez-Beltran A, Maclean F, Tsuzuki T, Werneck da Cunha I, Amin MB, Aning J, Aron M, Athanazio D, Bambury RM, Cheng L, Gopalan A, Gulmann C, Guo CC, Harris C, Iyer G, Jimenez RE, Jinzaki M, Kikuchi E, Lal P, Miyai K, Netto GJ, Pan CC, Panebianco V, van Rhijn BW, Siefker-Radtke A, Smith SC, Szarvas T, Wobker SE, Kristiansen G, Paner GP. The Dublin International Society of Urological Pathology (ISUP) Consensus Conference on Best Practice Recommendations on the Pathology of Urachal Neoplasms. Am J Surg Pathol, 2025. e-Pub 2025. PMID: 40471793.
4. Acosta, A, Saad, M, Chaux, A, Gordetsky, JB, Zheng, L, Guo, CC, Bikhet, M, Osunkoya, AO, Collins, K, Idrees, MT, Van Leenders, GJ, Gonzalez-Peramato, P, Cornejo, KM, Hirsch, M, Kao, CS, Matoso, A, Magi-Galluzzi, C, Rais-Bahrami, S. Differential Outcomes in Bladder Cancer After Neoadjuvant Chemotherapy. Urology 200:127-134, 2025. e-Pub 2025. PMID: 40250715.
5. Shen Y, Zheng L, Zhao J, Wang Y, Chen H, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Wei P, Hansel DE, Czerniak B, Guo CC. Molecular profile of micropapillary urothelial carcinoma of the urinary bladder: An analysis of 99 cases by next-generation sequencing. Hum Pathol 159:105812, 2025. e-Pub 2025. PMID: 40403852.
6. Jackson JC, Sanchez D, Joon AY, Estecio MR, Johns AC, Shah AY, Campbell M, Ward JF, Pisters LL, Guo CC, Zhang M, Zacharias NM, Tu SM. Bilateral Germ Cell Tumor of the Testis: Biological and Clinical Implications for a Stem Versus Genetic Origin of Cancers. Cells 14(9), 2025. e-Pub 2025. PMID: 40358182.
7. Zheng L, Tabet G, Guo CC, Rizvi YO, Raso MG, Liu J, Ding Q, Baraban E, Zhao J. Clinicopathological study of 34 cases of clear cell adenocarcinoma of the urinary tract and diagnostic value of SOX 17 in its differential diagnosis. Hum Pathol 157:105767, 2025. e-Pub 2025. PMID: 40189026.
8. Wang Y, Zang C, Li Z, Guo CC, Lai D, Wei P. A comparative study of statistical methods for identifying differentially expressed genes in spatial transcriptomics. bioRxiv, 2025. e-Pub 2025. PMID: 40027680.
9. Moussa MJ, Tabet GC, Siefker-Radtke AO, Xiao L, Wilson NR, Gao J, Logothetis CJ, Grivas P, Lee B, Shah AY, Msaouel P, Li R, Clemente LC, Zhao J, Tannir NM, Kamat AM, Hansel DE, Guo CC, Campbell MT, Alhalabi O. Histopathologic Progression and Metastatic Relapse Outcomes in Small Cell Neuroendocrine Carcinomas of the Urinary Tract. Cancer Med 14(2):e70594, 2025. e-Pub 2025. PMID: 39831734.
10. Myers AA, Fang AM, Moussa MJ, Hwang H, Wilson NR, Campbell MT, Msaouel P, Lee BH, Guo CC, Zhang M, Zhao J, Siefker-Radtke AO, Kamat AM, Alhalabi O. Impact of systemic therapy on clinical T1 small-cell neuroendocrine carcinoma of the bladder. ESMO Open 9(11):103964, 2024. e-Pub 2024. PMID: 39471563.
11. Tabet GC, Zheng L, Hosseini H, Ward J, Pisters L, Campbell MT, Tu SM, Czerniak B, Guo CC. Epithelioid trophoblastic tumor in male patients with germ cell tumor: A clinicopathologic analysis of five cases. Hum Pathol 153:105673, 2024. e-Pub 2024. PMID: 39461379.
12. Campbell MT, Shah AY, Msaouel P, Tannir NM, Siefker-Radtke AO, Kamat AM, Navai N, Dinney CPN, Rao P, Guo CC, Sheth RA, Venkatesan AM, Tidwell RS, Yadav SS, Gu A, Chen H, Macaluso M, Duan F, Basu S, Jindal S, Sharma P. A Pilot Study of the CD38 Antagonist Daratumumab in Patients with Metastatic Renal Cell Carcinoma or Muscle-Invasive Bladder Cancer. Cancer Res Commun 4(9):2444-2453, 2024. e-Pub 2024. PMID: 39207194.
13. Jackson JC, Sanchez D, Johns AC, Campbell MT, Aydin AM, Gokden N, Maraboyina S, Muesse JL, Ward JF, Pisters LL, Zacharias NM, Guo CC, Tu SM. Germ Cell Tumor of the Testis: Lethal Subtypes of a Curable Cancer. J Clin Med 13(12), 2024. e-Pub 2024. PMID: 38929965.
14. Zhao J, Shen Y, Guo M, Matin SF, Hansel DE, Guo CC. Diagnostic accuracy of upper tract urothelial carcinoma using biopsy, urinary cytology, and nephroureterectomy specimens: A tertiary cancer center experience. Am J Clin Pathol 162(5):492-499, 2024. e-Pub 2024. PMID: 38860463.
15. Contieri, R, Tan, WS, Grajales, V, Hensley, PJ, Martini, A, Bree, KK, Myers, AA, Nogueras Gonzalez, G, Navai, N, Dinney, CP, Guo, CC, Kamat, A. Influence of lamina propria invasion extension on T1 high-grade non-muscle-invasive bladder cancer in patients undergoing BCG or radical cystectomy. BJU international 133(6):733-741, 2024. e-Pub 2024. PMID: 38374533.
16. Zheng L, Chen H, Zhao J, Roy-Chowdhuri S, Kamat AM, Alhalabi O, Gao J, Siefker-Radtke A, Hansel DE, Czerniak B, Guo CC. Plasmacytoid urothelial carcinoma of the urinary bladder-A clinicopathological and molecular analysis of 52 cases. Hum Pathol 148:1-6, 2024. e-Pub 2024. PMID: 38679207.
17. Contieri R, Grajales V, Tan WS, Martini A, Sood A, Hensley P, Bree K, Lobo N, Nogueras-Gonzalez GM, Guo CC, Navai N, Dinney CP, Kamat AM. Impact of age >70 years on oncological outcomes in patients with non-muscle-invasive bladder cancer treated with Bacillus Calmette-Guérin. BJU Int 133(1):63-70, 2024. e-Pub 2023. PMID: 37442564.
18. Riddle N, Parkash V, Guo CC, Shen SS, Perincheri S, Ramirez AS, Auerbach A, Belchis D, Humphrey P. Recent Advances in Genitourinary Tumors Updates From the 5th Edition of the World Health Organization Blue Book Series. Arch Pathol Lab Med , 2023. e-Pub 2023.
19. Sood A, Rudzinski JK, Labbate CV, Hensley PJ, Bree KK, Guo CC, Alhalabi O, Campbell MT, Siefker-Radtke AO, Navai N, Dinney CPN, Gao J, Kamat AM. Long-Term Oncological Outcomes in Patients Diagnosed With Nonmetastatic Plasmacytoid Variant of Bladder Cancer: A 20-Year University of Texas MD Anderson Cancer Center Experience. J Urol, 2023. e-Pub 2023. PMID: 37922370.
20. Alhalabi O, Wilson N, Xiao L, Lin Y, Khandelwal J, Moussa MJ, Msaouel P, Navai N, Gao J, Kamat AM, Pilie P, Shah AY, Goswami S, Matin S, Kovitz C, Holla V, Guo C, Czerniak B, Logothetis C, Corn PG, Dinney CPN, Campbell MT, Hansel DE, Tannir NM, Siefker-Radtke AO. Comparative Effectiveness Analysis of Treatment Strategies for Surgically Resectable Neuroendocrine Carcinoma of the Urinary Tract. Eur Urol Oncol. e-Pub 2023. PMID: 37833193.
21. Tan WS, Grajales V, Contieri R, Hensley P, Bree K, Msaouel P, Guo CC, Nogueras-Gonzalez GM, Navai N, Dinney CP, Kamat AM. Bladder-sparing Treatment in Patients with Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: An Analysis of Long-term Survival Outcomes. Eur Urol Open Sci 53:16-22, 2023. e-Pub 2023. PMID: 37441349.
22. Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol 6(2):228-232, 2023. e-Pub 2023.
23. Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol 6(2):228-232, 2023. e-Pub 2023. PMID: 34789422.
24. Hensley PJ, Duan Z, Bree K, Sood A, Zhao H, Lobo N, Contieri R, Campbell MT, Guo CC, Navai N, Williams SB, Dinney CP, Kamat AM. Competing mortality risk from second primary malignancy in bladder cancer patients following radical cystectomy: Implications for survivorship. Urol Oncol 41(2):108.e11-108.e17, 2023. e-Pub 2023. PMID: 36404232.
25. Baraban, EG, Ding, CC, White, M, Vohra, P, Simko, JP, Boyle, K, Guo, CC, Zhang, M, Dobs, AS, Ketheeswaran, S, Liang, F, Epstein, J. Prostate Cancer in Male-to-Female Transgender Individuals. American Journal of Surgical Pathology 46(12):1650-1658, 2022. e-Pub 2022. PMID: 36006769.
26. Baraban E, Ding, CC, White, M, Vohra, P, Simko J, Boyle K, Guo C Zhang M, Dobs A, Ketheeswaran S, Liang F, Epstein JI. Prostate Cancer in Male-to-Female Transgender Individuals: Histopathologic Findings and Association With Gender-affirming Hormonal Therapy. American Journal of Surgical Pathology 46(12):1650-1658, 2022. e-Pub 2022.
27. Hensley PJ, Bree KK, Guo CC, Lobo N, Campbell MT, Pettaway CA, Kamat AM. Clinicopathological analysis and outcomes of inflammatory myofibroblastic tumours of the urinary bladder. BJU Int 130(5):604-610, 2022. e-Pub 2022. PMID: 34773684.
28. Labbate, CV, Hensley, PJ, Miest, T, Qiao, W, Adibi, M, Shah, AY, Chery, LJ, Papadopoulos, JN, Siefker-Radtke, AO, Gao, J, Guo, CC, Czerniak, BA, Navai, N, Kamat, A, Dinney, CP, Campbell, M, Matin, S. Longitudinal GFR trends after neoadjuvant chemotherapy prior to nephroureterectomy for upper tract urothelial carcinoma. Urologic Oncology: Seminars and Original Investigations 40(10):454.e17-454.e23, 2022. e-Pub 2022. PMID: 35961847.
29. Kinskey, JC, Schwartz, MR, Guo, CC, Ro, JY. Perivascular epithelioid cell tumor in the mediastinum. Human Pathology Reports 29, 2022. e-Pub 2022.
30. Guo CC, Czerniak B. Somatic-Type Malignancies in Testicular Germ Cell Tumors. Hum Pathol 127:123-135, 2022. e-Pub 2022. PMID: 35803413.
31. Zaleski, M, Chen, H, Roy Chowdhuri, S, Patel, KP, Luthra, R, Routbort, MJ, Kamat, A, Gao, J, Siefker-Radtke, AO, Czerniak, BA, Guo, CC. Distinct Gene Mutations Are Associated With Clinicopathologic Features in Urachal Carcinoma an analysis of 30 cases by next-generation Sequencing. American journal of clinical pathology 158(2):263-269, 2022. e-Pub 2022. PMID: 35467000.
32. Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM. Reply by Authors. J Urol 208(2):290-291, 2022. e-Pub 2022. PMID: 35770497.
33. Bree KK, Hensley PJ, Lobo N, Brooks NA, Nogueras-Gonzalez GM, Guo CC, Navai N, Grossman HB, Dinney CP, Kamat AM. All High-Grade Ta Tumors Should Be Classified as High Risk: Bacillus Calmette-Guérin Response in High-Grade Ta Tumors. J Urol 208(2):284-291, 2022. e-Pub 2022. PMID: 35770498.
34. Bondaruk, J, Jaksik, R, Wang, Z, Cogdell, D, Lee, S, Chen, Y, Dinh, KN, Majewski, T, Zhang, L, Cao, S, Tian, F, Yao, H, Kuś, P, Chen, H, Weinstein, JN, Navai, N, Dinney, CP, Gao, J, Theodorescu, D, Logothetis, CJ, Guo, CC, Wang, W, McConkey, DJ, Wei, P, Kimmel, M, Czerniak, BA. The origin of bladder cancer from mucosal field effects. iScience 25(7), 2022. e-Pub 2022. PMID: 35747385.
35. Adibi, M, McCormick, B, Economides, MP, Petros, FG, Xiao, L, Guo, CC, Shah, AY, Kamat, A, Dinney, CP, Navai, N, Gao, J, Siefker-Radtke, AO, Matin, S, Campbell, M. Five and Ten-Year Outcomes of Neoadjuvant Chemotherapy and Surgery for High-Risk Upper Tract Urothelial Carcinoma. Clinical Genitourinary Cancer 20(2):176-182, 2022. e-Pub 2022. PMID: 35039231.
36. Alhalabi O, Chen J, Zhang Y, Lu Y, Wang Q, Ramachandran S, Tidwell RS, Han G, Yan X, Meng J, Wang R, Hoang AG, Wang WL, Song J, Lopez L, Andreev-Drakhlin A, Siefker-Radtke A, Zhang X, Benedict WF, Shah AY, Wang J, Msaouel P, Zhang M, Guo CC, Czerniak B, Behrens C, Soto L, Papadimitrakopoulou V, Lewis J, Rinsurongkawong W, Rinsurongkawong V, Lee J, Roth J, Swisher S, Wistuba I, Heymach J, Wang J, Campbell MT, Efstathiou E, Titus M, Logothetis CJ, Ho TH, Zhang J, Wang L, Gao J. MTAP deficiency creates an exploitable target for antifolate therapy in 9p21-loss cancers. Nat Commun 13(1):1797, 2022. e-Pub 2022. PMID: 35379845.
37. Tu, S, Guo, CC, Chow, DS, Millward, NZ. Stem Cell Theory of Cancer. Cancers 14(6), 2022. e-Pub 2022. PMID: 35326699.
38. Moore, JA, Tidwell, R, Lehner, MJ, Campbell, M, Shah, AY, Zhang, M, Guo, CC, Ward, JF, Karam, JA, Wood, CG, Pisters, LL, Tu, S. Very Late Recurrence in Germ Cell Tumor of the Testis. Cancers 14(5), 2022. e-Pub 2022. PMID: 35267435.
39. Guo, CC, Duan, H, Fu, W, He, H, Xie, F, Yang, Z, Zheng, M, Zhang, L. A DNA damage response mutation-related prognostic gene signature associated with survival outcomes and the immune microenvironment in patients with hepatocellular carcinoma. Journal of biological regulators and homeostatic agents 36(1):45-56, 2022. e-Pub 2022.
40. Hwang MJ, Hamza A, Zhang M, Tu SM, Pisters LL, Czerniak B, Guo CC. Somatic-Type Malignancies in Testicular Germ Cell Tumors: A Clinicopathologic Study of 63 Cases. Am J Surg Pathol 46(1):11-17, 2022. e-Pub 2022. PMID: 34334690.
41. Han, G, Yang, G, Hao, D, Lu, Y, Thein, KZ, Simpson, BS, Chen, J, Sun, R, Alhalabi, O, Wang, R, Dang, M, Dai, E, Zhang, S, Nie, F, Zhao, S, Guo, CC, Hamza, A, Czerniak, BA, Cheng, C, Siefker-Radtke, AO, Bhat, KP, Futreal, A, Peng, G, Wargo, J, Peng, W, Kadara, HN, Ajani, JA, Swanton, C, Litchfield, K, Rodon Ahnert, J, Gao, J, Wang, L. 9p21 loss confers a cold tumor immune microenvironment and primary resistance to immune checkpoint therapy. Nature communications 12(1), 2021. e-Pub 2021. PMID: 34556668.
42. Hensley, PJ, Bree, KK, Campbell, M, Alhalabi, O, Kokorovic, A, Miest, T, Nogueras Gonzalez, G, Gao, J, Siefker-Radtke, AO, Guo, CC, Navai, N, Dinney, CP, Kamat, A. Reply by Authors. The Journal of Urology 206(5):1267, 2021. e-Pub 2021. PMID: 34372685.
43. Hensley, PJ, Bree, KK, Campbell, M, Alhalabi, O, Kokorovic, A, Miest, T, Nogueras Gonzalez, G, Gao, J, Siefker-Radtke, AO, Guo, CC, Navai, N, Dinney, CP, Kamat, A. Progression of Disease after Bacillus Calmette-Guérin Therapy. Journal of Urology 206(5):1258-1266, 2021. e-Pub 2021. PMID: 34184926.
44. Alhalabi O, Zhu Y, Hamza A, Qiao W, Lin Y, Wang RM, Shah AY, Campbell MT, Holla V, Kamat A, Wang WL, Wang J, Chen J, Meng J, Zhang M, Bondaruk J, Titus M, Genovese G, Czerniak BA, Shaw KR, Meric-Bernstam F, Guo CC, Logothetis CJ, Siefker-Radtke A, Msaouel P, Wang L, Liu J, Gao J. Integrative Clinical and Genomic Characterization of MTAP-deficient Metastatic Urothelial Cancer. Eur Urol Oncol S2588-9311(21):00188-7, 2021. e-Pub 2021.
45. Wang, G, Yuan, R, Zhou, C, Guo, CC, Villamil, C, Hayes, M, Eigl, B, Black, P. Urinary Large Cell Neuroendocrine Carcinoma. American Journal of Surgical Pathology 45(10):1399-1408, 2021. e-Pub 2021. PMID: 34074810.
46. Petros, FG, Choi, W, Qi, Y, Moss, T, Li, R, Su, X, Guo, CC, Czerniak, BA, Dinney, CP, McConkey, DJ, Matin, S. Expression Analysis of Same-Patient Metachronous and Synchronous Upper Tract and Bladder Urothelial Carcinoma. Journal of Urology 206(3):548-557, 2021. e-Pub 2021. PMID: 33881933.
47. Petros FG, Choi W, Qi Y, Moss T, Li R, Su X, Guo CC, Czerniak C, Dinney D, McConkey DJ, Matin SF. Expression Analysis of Same-Patient Metachronous and Synchronous Upper-Tract and Bladder Urothelial Carcinoma. J Urol 206(3):548-557, 2021. e-Pub 2021.
48. Amin MB, Comperat E, Epstein JI, True LD, Hansel D, Paner GP, Al-Ahmadie H, Baydar D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo CC, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, Netto G, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat S, Trpkov K, Weyerer V, Zhou M, McKenney J, Reuter VE. The Genitourinary Pathology Society Update on Classification and Grading of Flat and Papillary Urothelial Neoplasia With New Reporting Recommendations and Approach to Lesions With Mixed and Early Patterns of Neoplasia. Adv Anat Pathol 28(4):179-195, 2021. e-Pub 2021. PMID: 34128483.
49. Compérat E, Amin MB, Epstein JI, Hansel DE, Paner G, Al-Ahmadie H, True L, Bayder D, Bivalacqua T, Brimo F, Cheng L, Cheville J, Dalbagni G, Falzarano S, Gordetsky J, Guo C, Gupta S, Hes O, Iyer G, Kaushal S, Kunju L, Magi-Galluzzi C, Matoso A, McKenney J, Netto GJ, Osunkoya AO, Pan CC, Pivovarcikova K, Raspollini MR, Reis H, Rosenberg J, Roupret M, Shah RB, Shariat SF, Trpkov K, Weyerer V, Zhou M, Reuter V. The Genitourinary Pathology Society Update on Classification of Variant Histologies, T1 Substaging, Molecular Taxonomy, and Immunotherapy and PD-L1 Testing Implications of Urothelial Cancers. Adv Anat Pathol 28(4):196-208, 2021. e-Pub 2021. PMID: 34128484.
50. Fine, S, Trpkov, K, Amin, MB, Algaba, F, Aron, M, Baydar, D, Lopez-Beltran, A, Brimo, F, Cheville, JC, Colecchia, M, Comperat, EM, Costello, T, Cunha, IW, Delprado, W, DeMarzo, AM, Giannico, G, Gordetsky, JB, Guo, CC, Hansel, DE, Hirsch, M, Huang, J, Humphrey, PA, Jimenez, R, Khani, F, Kong, MX, Kryvenko, ON, Kunju, LP, Lal, P, Latour, M, Lotan, TL, Maclean, F, Magi-Galluzzi, C, Mehra, R, Menon, S, Miyamoto, H, Montironi, R, Netto, G, Nguyen, JK, Osunkoya, AO, Parwani, AV, Pavlovich, CP, Robinson, B, Rubin, MA, Shah, RB, So, JS, Takahashi, H, Tavora, F, Tretiakova, M, True, LD, Wobker, SE, Yang, XJ, Zhou, M, Zynger, DL, Epstein, J. Practice patterns related to prostate cancer grading. Urologic Oncology: Seminars and Original Investigations 39(5):295.e1-295.e8, 2021. e-Pub 2021. PMID: 32948433.
51. Epstein JI, Amin MB, Fine SW, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, Gordetsky JB, Guo CC, Hansel DE, Hirsch MS, Huang J, Humphrey PA, Jimenez RE, Khani F, Kong Q, Kryvenko ON, Kunju LP, Lal P, Latour M, Lotan T, Maclean F, Magi-Galluzzi C, Mehra R, Menon S, Miyamoto H, Montironi R, Netto GJ, Nguyen JK, Osunkoya AO, Parwani A, Robinson BD, Rubin MA, Shah RB, So JS, Takahashi H, Tavora F, Tretiakova MS, True L, Wobker SE, Yang XJ, Zhou M, Zynger DL, Trpkov K. The 2019 Genitourinary Pathology Society (GUPS) White Paper on Contemporary Grading of Prostate Cancer. Arch Pathol Lab Med 145(4):461-493, 2021. e-Pub 2021. PMID: 32589068.
52. Gao J, Navai N, Alhalabi O, Siefker-Radtke A, Campbell MT, Tidwell RS, Guo CC, Kamat AM, Matin SF, Araujo JC, Shah AY, Msaouel P, Corn P, Wang J, Papadopoulos JN, Yadav SS, Blando JM, Duan F, Basu S, Liu W, Shen Y, Zhang Y, Macaluso MD, Wang Y, Chen J, Zhang J, Futreal A, Dinney C, Allison JP, Goswami S, Sharma P. Neoadjuvant PD-L1 plus CTLA-4 blockade in patients with cisplatin-ineligible operable high-risk urothelial carcinoma. Nat Med 26(12):1845-1851, 2020. e-Pub 2020.
53. Hamza A, Hwang MJ, Czerniak BA, Guo CC. Secondary tumors of the bladder: A survival outcome study. Ann Diagn Pathol 48:151593, 2020. e-Pub 2020. PMID: 32836180.
54. Fine SW, Trpkov K, Amin MB, Algaba F, Aron M, Baydar DE, Beltran AL, Brimo F, Cheville JC, Colecchia M, Comperat E, Costello T, da Cunha IW, Delprado W, DeMarzo AM, Giannico GA, Gordetsky JB, Guo CC, Hansel DE, Hirsch MS, Huang J, Humphrey PA, Jimenez RE, Khani F, Kong MX, Kryvenko ON, Kunju LP, Lal P, Latour M, Lotan T, Maclean F, Magi-Galluzzi C, Mehra R, Menon S, Miyamoto H, Montironi R, Netto GJ, Nguyen JK, Osunkoya AO, Parwani A, Pavlovich CP, Robinson BD, Rubin MA, Shah RB, So JS, Takahashi H, Tavora F, Tretiakova MS, True L, Wobker SE, Yang XJ, Zhou M, Zynger DL, Epstein JI. Practice patterns related to prostate cancer grading: results of a 2019 Genitourinary Pathology Society clinician survey. Urol Oncol S20:1078-1439, 2020. e-Pub 2020.
55. Hwang MJ, Kamat AM, Dinney CP, Czerniak B, Guo CC. Bladder Cancer Involving Smooth Muscle of Indeterminate Type or Muscularis Mucosae in Transurethral Biopsy Specimens. Am J Clin Pathol 154(2):208-214, 2020. e-Pub 2020. PMID: 32253420.
56. Guo CC, Bondaruk J, Yao H, Wang Z, Zhang L, Lee S, Lee JG, Cogdell D, Zhang M, Yang G, Dadhania V, Choi W, Wei P, Gao J, Theodorescu D, Logothetis C, Dinney C, Kimmel M, Weinstein JN, McConkey DJ, Czerniak B. Assessment of Luminal and Basal Phenotypes in Bladder Cancer. Sci Rep 10(1):9743, 2020. e-Pub 2020. PMID: 32546765.
57. Hamza A, Guo CC. Perivascular Epithelioid Cell Tumor of the Urinary Bladder: A Systematic Review. Int J Surg Pathol 28(4):393-400, 2020. e-Pub 2020. PMID: 31865807.
58. Yang G, Bondaruk J, Cogdell D, Wang Z, Lee S, Lee JG, Zhang S, Choi W, Wang Y, Wang G, Yao H, Dadhania V, Logothetis C, Siefker-Radtke A, Kamat A, Dinney C, Theodorescu D, Kimmel K, Wei P, Liang Y, Guo CC, Weinstein JN, McConkey DJ, Czerniak B. Urothelial-to-Neural Plasticity Drives Progression to Small Cell Bladder Cancer. iScience 23(6):101201, 2020. e-Pub 2020. PMID: 32521509.
59. Duplisea JJ, Petros FG, Li R, Fellman B, Guo CC, Czerniak BA, Siefker-Radtke AO, Araujo JC, Dinney CPN, Matin SF. Outcomes of nonmetastatic micropapillary variant upper tract urothelial carcinoma. Urol Oncol 37(6):354.e19-354.e26, 2019. e-Pub 2019. PMID: 30777393.
60. Guo CC, Majewski T, Zhang L, Yao H, Bondaruk J, Wang Y, Zhang S, Wang Z, Lee JG, Lee S, Cogdell D, Zhang M, Wei P, Grossman HB, Kamat A, Duplisea JJ, Ferguson JE, Huang H, Dadhania V, Gao J, Dinney C, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Dysregulation of EMT Drives the Progression to Clinically Aggressive Sarcomatoid Bladder Cancer. Cell Rep 27(6):1781-1793.e4, 2019. e-Pub 2019. PMID: 31067463.
61. Li R, Metcalfe MJ, Tabayoyong WB, Guo CC, Nogueras González GM, Navai N, Grossman HB, Dinney CP, Kamat AM. Using Grade of Recurrent Tumor to Guide Further Therapy While on Bacillus Calmette-Guerin: Low-grade Recurrences Are not Benign. Eur Urol Oncol 2(3):286-293, 2019. e-Pub 2019. PMID: 31200843.
62. Majewski T, Yao H, Bondaruk J, Chung W, Lee S, Lee JG, Zhang S, Cogdell D, Yang G, Choi W, Dinney C, Grossman HB, Logothetis C, Scherer SE, Guo CC, Zhang L, Wei P, Weinstein JN, Issa JP, Baggerly K, McConkey DJ, Czerniak B. Whole-Organ Genomic Characterization of Mucosal Field Effects Initiating Bladder Carcinogenesis. Cell Rep 26(8):2241-2256, 2019. e-Pub 2019. PMID: 30784602.
63. Li R, Tabayoyong WB, Guo CC, González GMN, Navai N, Grossman HB, Dinney CP, Kamat AM. Prognostic Implication of the United States Food and Drug Administration-defined BCG-unresponsive Disease. Eur Urol 75(1):8-10, 2019. e-Pub 2019. PMID: 30301695.
64. Wang G, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Small cell carcinoma of the urinary bladder: a Clinicopathologic and Immunohistochemical analysis of 81 cases. Hum Pathol 79(9):57-65, 2018. e-Pub 2018. PMID: 29763719.
65. Murugan P, Rao P, Tamboli P, Czerniak B, Guo CC. Primary Ewing Sarcoma / Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Pathol Oncol Res 24(1):153-159, 2018. e-Pub 2018. PMID: 28429277.
66. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat AM, Campbell M, Dinney C. Impact of High-risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus 3(6):577-583, 2017. e-Pub 2017. PMID: 28753816.
67. Metcalfe MJ, Ferguson JE, Li R, Xiao L, Guo CC, Czerniak BA, Siefker-Radtke A, Pretzsch SM, Navai N, McConkey DJ, Kamat, AM, Campbell M, Dinney CP. The Impact of High Risk Features and Effect of Neoadjuvant Chemotherapy in Urothelial Cancer Patients with Invasion Into the Lamina Propria on Transurethral Resection in the Absence of Deep Muscle Invasion. Eur Urol Focus 3(6):577-583, 2017. e-Pub 2017.
68. Rieken M, Shariat SF, Karam JA, Foerster B, Khani F, Gust K, Abufaraj M, Wood CG, Weizer AZ, Raman JD, Guo CC, Rioux-Leclercq N, Haitel A, Bensalah K, Lotan Y, Bachmann A, De Marzo AM, Robinson BD, Margulis V. Frequency and prognostic value of PTEN loss in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 27(12):5652-5662, 2017. e-Pub 2017. PMID: 28709887.
69. Moss TJ, Qi Y, Xi L, Peng B, Kim TB, Ezzedine NE, Mosqueda ME, Guo CC, Czerniak BA, Ittmann M, Wheeler DA, Lerner SP, Matin SF. Comprehensive Genomic Characterization of Upper Tract Urothelial Carcinoma. Eur Urol 72(4):641-649, 2017. e-Pub 2017. PMID: 28601352.
70. Wang G, Huang H, Kamat AM, Siefker-Radtke A, Dinney CP, Troncoso P, Czerniak B, Guo CC. High-Grade Neuroendocrine Carcinoma of the Urachus - Report of 3 Cases. Hum Pathol 67(9):126-133, 2017. e-Pub 2017. PMID: 28823575.
71. Metcalfe MJ, Troncoso P, Guo CC, Chen HC, Bozkurt Y, Ward JF, Pisters LL. Salvage Prostatectomy for Post Radiation Adenocarcinoma with Treatment Effect, Pathological and Oncological Outcomes. Can Urol Assoc J 11(7):E277-84, 2017. e-Pub 2017. PMID: 28761588.
72. Gilani S, Guo CC, Li-Ning EM, Pettaway C, Troncoso P. Transformation of prostatic adenocarcinoma to well differentiated neuroendocrine tumor after hormonal treatment. Hum Pathol 64(6):186-190, 2017. e-Pub 2017. PMID: 28159676.
73. Roth B, Jayaratna I, Sundi D, Cheng T, Melquist J, Choi W, Porten S, Nitti G, Navai N, Wszolek M, Guo C, Czerniak B, McConkey D, Dinney C. Employing an orthotopic model to study the role of epithelial-mesenchymal transition in bladder cancer metastasis. Oncotarget 8(21):34205-34222, 2017. e-Pub 2017. PMID: 27494900.
74. Fox MD, Xiao L, Zhang M, Kamat AM, Siefker-Radtke A, Zhang L, Dinney CP, Czerniak B, Guo CC. Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Analysis of 49 Cases. Am J Clin Pathol 147(5):500-506, 2017. e-Pub 2017. PMID: 28371875.
75. Fernández MI, Williams SB, Willis DL, Slack RS, Dickstein RJ, Parikh S, Chiong E, Siefker-Radtke AO, Guo CC, Czerniak BA, McConkey DJ, Shah JB, Pisters LL, Grossman HB, Dinney CP, Kamat AM. Clinical Risk Stratification in Patients with Surgically Resectable Micropapillary Bladder Cancer. BJU Int 119(5):684-691, 2017. e-Pub 2017. PMID: 27753185.
76. Mobley A, Zhang S, Bondaruk J, Wang Y, Majewski T, Caraway NP, Huang L, Shoshan E, Velazquez-Torres G, Nitti G, Lee S, Lee JG, Fuentes-Mattei E, Willis D, Zhang L, Guo CC, Yao H, Baggerly K, Lotan Y, Lerner SP, Dinney C, McConkey D, Bar-Eli M, Czerniak B. Aurora Kinase A is a Biomarker for Bladder Cancer Detection and Contributes to its Aggressive Behavior. Sci Rep 7(40714):40714, 2017. e-Pub 2017. PMID: 28102366.
77. Mmeje CO, Guo CC, Shah JB, Navai N, Grossman HB, Dinney CP, Kamat AM. Papillary Recurrence of Bladder Cancer at First Evaluation after Induction Bacillus Calmette-Guérin Therapy: Implication for Clinical Trial Design. Eur Urol 70(5):778-785, 2016. e-Pub 2016. PMID: 26922408.
78. Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Meta-Analysis of the Luminal and Basal Subtypes of Bladder Cancer and the Identification of Signature Immunohistochemical Markers for Clinical Use. EBioMedicine 12:105-117, 2016. e-Pub 2016. PMID: 27612592.
79. *Guo CC, Dadhania V, Zhang L, Majewski T, Bondaruk J, Sykulski M, Wronowska W, Gambin A, Wang Y, Zhang S, Fuentes-Mattei E, Kamat AM, Dinney C, Siefker-Radtke A, Choi W, Baggerly KA, McConkey D, Weinstein JN, Czerniak B. Gene Expression Profile of the Clinically Aggressive Micropapillary Variant of Bladder Cancer. Eur Urol 70(4):611-620, 2016. e-Pub 2016. PMID: 26988609.
80. Siefker-Radtke A, Zhang XQ, Guo CC, Shen Y, Pirollo KF, Sabir S, Leung C, Leong-Wu C, Ling CM, Chang EH, Millikan RE, Benedict WF. A Phase l Study of a Tumor-targeted Systemic Nanodelivery System, SGT-94, in Genitourinary Cancers. Mol Ther 24(8):1484-91, 2016. e-Pub 2016. PMID: 27480598.
81. * Dhillon J, Liang Y, Kamat AM, Siefker-Radtke A, Dinney CP, Czerniak B, Guo CC. Urachal carcinoma: a pathologic and clinical study of 46 cases. Hum Pathol 46(12):1808-14, 2015. e-Pub 2015. PMID: 26364859.
82. Willis DL, Fernandez MI, Dickstein RJ, Parikh S, Shah JB, Pisters LL, Guo CC, Henderson S, Czerniak BA, Grossman HB, Dinney CP, Kamat AM. Insulin-like Growth Factor Messenger RNA-binding Protein 3 Expression Helps Clinical Outcomes in cT1 Micropapillary Bladder Cancer. J Urol 193(4):1129-34, 2015. e-Pub 2015. PMID: 25254936.
83. * Li W, Liang Y, Deavers MT, Kamat AM, Matin SF, Dinney CP, Czerniak B, Guo CC. Uroplakin II is a more sensitive immunohistochemical marker than uroplakin III in urothelial carcinoma and its variants. Am J Clin Pathol 142(6):864-71, 2014. e-Pub 2014. PMID: 25389341.
84. Iczkowski KA, Egevad L, Ma J, Harding-Jackson N, Algaba F, Billis A, Camparo P, Cheng L, Clouston D, Comperat EM, Datta MW, Evans AG, Griffiths DF, Guo CC, Hailemariam S, Huang W, Humphrey PA, Jiang Z, Kahane H, Kristiansen G, La Rosa FG, Lopez-Beltran A, MacLennan GT, Magi-Galluzzi C, Merrimen J, Montironi R, Osunkoya AO, Picken MM, Rao N, Shah RB, Shanks JH, Shen SS, Tawfik OW, True LD, Van der Kwast T, Varma M, Wheeler TM, Zynger DL, Sahr N, Bostwick DG. Intraductal carcinoma of the prostate: interobserver reproducibility survey of 39 urologic pathologists. Ann Diagn Pathol 18(6):333-342, 2014. e-Pub 2014. PMID: 25263387.
85. Lee DJ, Xylinas E, Rieken M, Khani F, Klatte T, Wood CG, Karam JA, Weizer AZ, Raman JD, Remzi M, Guo CC, Rioux-Leclercq N, Haitel A, Bolenz C, Bensalah K, Sagalowsky AI, Montorsi F, Lotan Y, Shariat SF, Robinson BD, Margulis V. Insulin-like Growth Factor Messenger RNA-binding Protein 3 Expression Helps Prognostication in Patients with Upper Tract Urothelial Carcinoma. Eur Urol 66(2):379-385, 2014. e-Pub 2014. PMID: 24388440.
86. * Liang Y, Heitzman J, Kamat AM, Dinney CP, Czerniak B, Guo CC. Differential expression of GATA-3 in urothelial carcinoma variants. Hum Pathol 45(7):1466-72, 2014. e-Pub 2014. PMID: 24745616.
87. * Nicolas MM, Nazarullah A, Guo CC. Sarcomatoid urothelial carcinoma with chondrosarcomatous differentiation of the ureter: a case report. Anal Quant Cytopathol Histpathol 36(2):111-6, 2014. e-Pub 2014. PMID: 24902363.
88. Vicens RA, Balachandran A, Guo CC, Vikram R. Multimodality imaging of thyroid-like follicular renal cell carcinoma with lung metastases, a new emerging tumor entity. Abdom Imaging 39(2):388-93, 2014. e-Pub 2014. PMID: 24343809.
89. Guo CC) TCGARN(. Comprehensive molecular characterization of urothelial bladder carcinoma. Nature 507(7492):315-322, 2014. e-Pub 2014. PMID: 24476821.
90. * Tarrant WP, Czerniak BA, Guo CC. Relationship between Primary and Metastatic Testicular Germ Cell Tumors: A Clinicopathologic Analysis of 100 Cases. Hum Pathol 44(10):2220-2226, 2013. e-Pub 2013. PMID: 23856516.
91. * Stanton ML, Xiao L, Czerniak BA, Guo CC. Urothelial Tumors of the Urinary Bladder in Young Patients: A Clinicopathologic Study of 59 Cases. Arch Pathol Lab Med 137(10):1337-1344, 2013. e-Pub 2013. PMID: 24079760.
92. Som A, Xiao L, Zhu R, Guo CC, Xiao L, Rao P, Efstathiou E, Matin A, Tu SM. Clinically atypical seminomas with yolk sac tumor features. Can J Urol 20(4):6860-7, 2013. e-Pub 2013. PMID: 23930614.
93. Qi W, White WC, Choi W, Guo CC, Dinney C, McConkey DJ, Siefker-Radtke A. Inhibition of inducible heat shock protein-70 (HSP72) enhances bortezomib-induced cell death in human bladder cancer cells. Plos One 8(7), 2013. e-Pub 2013. PMID: 23874968.
94. Shariat SF, Zigeuner R, Rink M, Margulis V, Hansen J, Kikuchi E, Kassouf W, Raman JD, Remzi M, Koppie TM, Bensalah K, Guo CC, Mikami S, Sircar K, Ng CK, Haitel A, Kabbani W, Chun FK, Wood CG, Scherr DS, Karakiewicz PI, Langner C. Subclassification of pT3 Urothelial Carcinoma of the Renal Pelvicalyceal System is Associated With Recurrence-Free and Cancer-Specific Survival: Proposal for a Revision of the Current TNM Classification. Eur Urol 62(2):224-31, 2012. e-Pub 2012. PMID: 22285763.
95. Rink M, Robinson BD, Green DA, Cha EK, Hansen J, Comploj E, Margulis V, Raman JD, Ng CK, Remzi M, Bensalah K, Kabbani W, Haitel A, Rioux-Leclercq N, Guo CC, Chun FK, Kikuchi E, Kassouf W, Sircar K, Sun M, Sonpavde G, Lotan Y, Pycha A, Karakiewicz PI, Scherr DS, Shariat SF. Impact of histological variants on clinical outcomes of patients with upper urinary tract urothelial carcinoma. J Urol 188(2):398-404, 2012. e-Pub 2012. PMID: 22698626.
96. Som A, Zhu R, Guo CC, Efstathiou E, Xiao L, Pisters LL, Matin A, Tu SM. Recurrent seminomas: Clinical features and biologic implications. Urol Oncol 30(4):494-501, 2012. e-Pub 2012. PMID: 20822932.
97. Leibovici D, Chiong E, Pisters LL, Guo CC, Ward JF, Andino L, Prokhorova IN, Troncoso P. Pathological characteristics of prostate cancer recurrence after radiation therapy: implications for focal salvage therapy. J Urol 188(1):98-102, 2012. e-Pub 2012. PMID: 22578724.
98. * Guo CC, Wang Y, Xiao L, Troncoso P, Czerniak BA. The relationship of TMPRSS2-ERG gene fusion between primary and metastatic prostate cancers. Hum Pathol 43(5):644-9, 2012. e-Pub 2012. PMID: 21937078.
99. * Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA, Shen SS, Guo CC. Primary small cell carcinoma of the kidney: A clinicopathologic study of 14 cases. Hum Pathol 42(11):1792-8, 2011. e-Pub 2011. PMID: 21733553.
100. Youssef RF, Shariat SF, Lotan Y, Wood CG, Sagalowsky AI, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Kabbani W, Langner C, Guo CC, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Margulis V. Upper urinary tract urothelial carcinoma with loco-regional nodal metastases: insights from the Upper Tract Urothelial Carcinoma Collaboration. BJU Int 108(8):1286-1291, 2011. e-Pub 2011. PMID: 21332905.
101. Mathew P, Tannir N, Tu SM, Wen S, Guo CC, Marcott V, Bekele BN, Pagliaro L. Accelerated disease progression in prostate cancer and bone metastases with platelet-derived growth factor receptor inhibition: observations with tandutinib. Cancer Chemother Pharmacol 68(4):889-96, 2011. e-Pub 2011. PMID: 21290244.
102. * Xiao L, Zhu XZ, Wang Y, Gong Y, Guo CC. [TMPRSS2-ERG gene fusion in metastatic prostate cancers: a study of fine needle aspiration specimens]. Zhonghua Bing Li Xue Za Zhi 40(6):392-6, 2011. e-Pub 2011. PMID: 21914348.
103. Cao D, Allan RW, Cheng L, Peng Y, Guo CC, Dahiya N, Akhi S, Li J. RNA-binding protein LIN28 is a marker for testicular germ cell tumors. Hum Pathol 42(5):710-8, 2011. e-Pub 2011. PMID: 21288558.
104. *Guo CC, Dancer JY, Wang Y, Aparicio A, Navone NM, Troncoso P, Czerniak BA. TMPRSS2-ERG Gene Fusion in Small Cell Carcinoma of the Prostate. Hum Pathol 42(1):11-17, 2011. e-Pub 2011. PMID: 21040948.
105. Tan PH, Cheng L, Srigley JR, Griffiths D, Humphrey PA, van der Kwast TH, Montironi R, Wheeler TM, Delahunt B, Egevad L, Epstein JI, Guo CC) IPCG(. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 5: surgical margins. Mod Pathol 24(1):48-57, 2011. e-Pub 2011.
106. Berney DM, Wheeler TM, Grignon DJ, Epstein JI, Griffiths DF, Humphrey PA, van der Kwast T, Montironi R, Delahunt B, Egevad L, Srigley JR, Guo CC) IPCG(. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 4: seminal vesicles and lymph nodes. Mod Pathol 24(1):39-47, 2011. e-Pub 2011.
107. van der Kwast TH, Amin MB, Billis A, Epstein JI, Griffiths D, Humphrey PA, Montironi R, Wheeler TM, Srigley JR, Egevad L, Delahunt B, Guo CC) IPCG(. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 2: T2 substaging and prostate cancer volume. Mod Pathol 24(1):16-25, 2011. e-Pub 2011.
108. Magi-Galluzzi C, Evans AJ, Delahunt B, Epstein JI, Griffiths DF, van der Kwast TH, Montironi R, Wheeler TM, Srigley JR, Egevad LL, Humphrey PA, Guo CC) IPCG(. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 3: extraprostatic extension, lymphovascular invasion and locally advanced disease. Mod Pathol 24(1):26-38, 2011. e-Pub 2011.
109. Samaratunga H, Montironi R, True L, Epstein JI, Griffiths DF, Humphrey PA, van der Kwast T, Wheeler TM, Srigley JR, Delahunt B, Egevad L, Guo CC) IPCG(. International Society of Urological Pathology (ISUP) Consensus Conference on Handling and Staging of Radical Prostatectomy Specimens. Working group 1: specimen handling. Mod Pathol 24(1):6-15, 2011. e-Pub 2011.
110. * Dhillon J, Tannir NM, Matin SF, Tamboli P, Czerniak BA, Guo CC. Thyroid-like follicular carcinoma of the kidney with metastases to the lungs and retroperitoneal lymph nodes. Hum Pathol 42(1):146-150, 2011. e-Pub 2011. PMID: 20971497.
111. Aparicio A, Tzelepi V, Araujo JC, Guo CC, Liang S, Troncoso P, Logothetis CJ, Navone NM, Maity SN. Neuroendocrine prostate cancer xenografts with large-cell and small-cell features derived from a single patient's tumor: Morphological, immunohistochemical, and gene expression profiles. Prostate 71(8):846-56. e-Pub 2010. PMID: 21086505.
112. Wang P, Li J, Allan RW, Guo CC, Peng Y, Cao D. Expression of UTF1 in primary and metastatic testicular germ cell tumors. Am J Clin Pathol 134(4):604-12, 2010. e-Pub 2010. PMID: 20855642.
113. Margulis V, Youssef RF, Karakiewicz PI, Lotan Y, Wood CG, Zigeuner R, Kikuchi E, Weizer A, Raman JD, Remzi M, Roscigno M, Montorsi F, Bolenz C, Kassouf W, Shariat SF, Guo CC) UTUCCG(. Preoperative multivariable prognostic model for prediction of nonorgan confined urothelial carcinoma of the upper urinary tract. J Urol 184(2):453-8, 2010. e-Pub 2010. PMID: 20620397.
114. Cao D, Lane Z, Allan RW, Wang P, Guo CC, Peng Y, Li J. TCL1 is a diagnostic marker for intratubular germ cell neoplasia and classic seminoma. Histopathology 57(1):152-7, 2010. e-Pub 2010. PMID: 20553335.
115. * Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Mediastinal germ cell tumors with an angiosarcomatous component: a report of 12 cases. Hum Pathol 41(6):832-7, 2010. e-Pub 2010. PMID: 20153508.
116. Brimo F, Robinson B, Guo CC, Zhou M, Latour M, Epstein JI. Renal epithelioid angiomyolipoma with atypia: a series of 40 cases with emphasis on clinicopathologic prognostic indicators of malignancy. Am J Surg Pathol 34(5):715-22, 2010. e-Pub 2010. PMID: 20410812.
117. Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI. Smooth muscle neoplasms of the urinary bladder: a clinicopathologic study of 51 cases. Am J Surg Pathol 34(4):502-9, 2010. e-Pub 2010. PMID: 20154594.
118. Wang WP, Guo CC, Berney DM, Ulbright TM, Ubright TM, Hansel DE, Shen R, Ali T, Epstein JI. Primary carcinoid tumors of the testis: a clinicopathologic study of 29 cases. Am J Surg Pathol 34(4):519-24, 2010. e-Pub 2010. PMID: 20351489.
119. * Nicolas MM, Sanchez-Salazar AJ, Guo CC. Plasmacytoid urothelial carcinoma of the urinary bladder: two cases report. Basic and Applied Pathology 3:105-108, 2010. e-Pub 2010.
120. Miller JS, Zhou M, Brimo F, Guo CC, Epstein JI. Primary leiomyosarcoma of the kidney: a clinicopathologic study of 27 cases. Am J Surg Pathol 34(2):238-42, 2010. e-Pub 2010. PMID: 20090506.
121. Zigeuner R, Shariat SF, Margulis V, Karakiewicz PI, Roscigno M, Weizer A, Kikuchi E, Remzi M, Raman JD, Bolenz C, Bensalah K, Capitanio U, Koppie TM, Kassouf W, Sircar K, Patard JJ, Fernández MI, Wood CG, Montorsi F, Ströbel P, Wheat JC, Haitel A, Oya M, Guo CC, Ng C, Chade DC, Sagalowsky A, Langner C. Tumour Necrosis Is an Indicator of Aggressive Biology in Patients with Urothelial Carcinoma of the Upper Urinary Tract. Eur Urol 57(4):575-81. e-Pub 2009. PMID: 19959276.
122. Roscigno M, Shariat SF, Freschi M, Margulis V, Karakiewicz P, Suardi N, Remzi M, Zigeuner R, Bolenz C, Kikuchi E, Weizer A, Bensalah K, Sagalowsky A, Koppie TM, Raman J, Fernández M, Ströbel P, Kabbani W, Langner C, Wheat J, Guo CC, Kassouf W, Haitel A, Wood CG, Montorsi F. Assessment of the minimum number of lymph nodes needed to detect lymph node invasion at radical nephroureterectomy in patients with upper tract urothelial cancer. Urology 74(5):1070-4, 2009. e-Pub 2009. PMID: 19883824.
123. * Guo CC, Gomez E, Tamboli P, Bondaruk JE, Kamat A, Bassett R, Dinney CP, Czerniak BA. Squamous Cell Carcinoma of the Urinary Bladder: A Clinicopathologic and Immunohistochemical Study of 16 Cases. Hum Pathol 40(10):1448-52, 2009. e-Pub 2009. PMID: 19454359.
124. Trock BJ, Guo CC, Gonzalgo ML, Magheli A, Loeb S, Epstein JI. Tertiary Gleason patterns and biochemical recurrence after prostatectomy: proposal for a modified Gleason scoring system. J Urol 182(4):1364-70, 2009. e-Pub 2009. PMID: 19683280.
125. * Guo CC, Punar M, Contreras AL, Tu SM, Pisters L, Tamboli P, Czerniak B. Testicular Germ Cell Tumors with Sarcomatous Components: An Analysis of 33 cases. Am J Surg Pathol 33(8):1173-8, 2009. e-Pub 2009. PMID: 19561445.
126. * Guo CC, Zuo G, Cao D, Troncoso P, Czerniak BA. Prostate cancer of transition zone origin lacks TMPRSS2-ERG gene fusion. Mod Pathol 22(7):866-71, 2009. e-Pub 2009. PMID: 19396154.
127. Capitanio U, Shariat SF, Isbarn H, Weizer A, Remzi M, Roscigno M, Kikuchi E, Raman JD, Bolenz C, Bensalah K, Koppie TM, Kassouf W, Fernández MI, Ströbel P, Wheat J, Zigeuner R, Langner C, Waldert M, Oya M, Guo CC, Ng C, Montorsi F, Wood CG, Margulis V, Karakiewicz PI. Comparison of oncologic outcomes for open and laparoscopic nephroureterectomy: a multi-institutional analysis of 1249 cases. Eur Urol 56(1):1-9, 2009. e-Pub 2009. PMID: 19361911.
128. Tu SM, Lopez A, Leibovici D, Bilen MA, Evliyaoglu F, Aparicio A, Guo CC, Kuban DA, Johnson MM, Pisters LL. Ductal adenocarcinoma of the prostate - clinical features and implications after local therapy. Cancer 115(13):2872-80, 2009. e-Pub 2009. PMID: 19402048.
129. Cao D, Li J, Guo CC, Allan RW, Humphrey PA. SALL4 Is a Novel Diagnostic Marker for Testicular Germ Cell Tumors. Am J Surg Pathol 33(7):1065-77, 2009. e-Pub 2009. PMID: 19390421.
130. Roscigno M, Shariat SF, Margulis V, Karakiewicz P, Remzi M, Kikuchi E, Langner C, Lotan Y, Weizer A, Bensalah K, Raman JD, Bolenz C, Guo CC, Wood CG, Zigeuner R, Wheat J, Kabbani W, Koppie TM, Ng CK, Suardi N, Bertini R, Fernández MI, Mikami S, Isida M, Michel MS, Montorsi F. Impact of lymph node dissection on cancer specific survival in patients with upper tract urothelial carcinoma treated with radical nephroureterectomy. J Urol 181(6):2482-9, 2009. e-Pub 2009. PMID: 19371878.
131. Margulis V, Shariat SF, Matin SF, Kamat AM, Zigeuner R, Kikuchi E, Lotan Y, Weizer A, Raman JD, Wood CG, Guo CC) UTUCCG(. Outcomes of radical nephroureterectomy: a series from the Upper Tract Urothelial Carcinoma Collaboration. Cancer 115(6):1224-33, 2009. e-Pub 2009. PMID: 19156917.
132. Remzi M, Haitel A, Margulis V, Karakiewicz P, Montorsi F, Kikuchi E, Zigeuner R, Weizer A, Bolenz C, Bensalah K, Suardi N, Raman JD, Lotan Y, Waldert M, Ng CK, Fernández M, Koppie TM, Ströbel P, Kabbani W, Murai M, Langner C, Roscigno M, Wheat J, Guo CC, Wood CG, Shariat SF. Tumour architecture is an independent predictor of outcomes after nephroureterectomy: a multi-institutional analysis of 1363 patients. BJU Int 103(3):307-11, 2009. e-Pub 2009. PMID: 18990163.
133. * Guo CC, Tamboli P, Czerniak B. Micropapillary variant of urothelial carcinoma in the upper urinary tract: a clinicopathologic study of 11 cases. Arch Pathol Lab Med 133(1):62-6, 2009. e-Pub 2009. PMID: 19123738.
134. Iyer RB, Guo CC, Perrier N. Adrenal pheochromocytoma with surrounding brown fat stimulation. AJR Am J Roentgenol 192(1):300-1, 2009. e-Pub 2009. PMID: 19098214.
135. * Guo CC, Pisters LL, Troncoso P. Prostate cancer invading the rectum: a clinicopathological study of 18 cases. Pathology 41(6):539-43, 2009. e-Pub 2009. PMID: 19900102.
136. * Guo CC, Yang G, Khun K, Kong X, Levy D, Lee P, Melamed J. Activation of Stat3 in renal tumors. Am J Transl Res 1(3):283-90, 2009. e-Pub 2009. PMID: 19956438.
137. * Ricketts R, Tamboli P, Czerniak B, Guo CC. Tumor-to-tumor metastasis: report of 2 cases of metastatic carcinoma to angiomyolipoma of the kidney. Arch Pathol Lab Med 132(6):1016-20, 2008. e-Pub 2008. PMID: 18517262.
138. Kassouf W, Spiess PE, Siefker-Radtke A, Swanson D, Grossman HB, Kamat AM, Munsell MF, Guo CC, Czerniak BA, Dinney CP. Outcome and patterns of recurrence of nonbilharzial pure squamous cell carcinoma of the bladder: A contemporary review of The University of Texas M.D. Anderson Cancer Center experience. Cancer 110(4):764-769, 2007. e-Pub 2007. PMID: 17614317.
139. * Guo CC, Epstein JI. Intraductal carcinoma of the prostate on needle biopsy: Histologic features and clinical significance. Mod Pathol 19(12):1528-35, 2006. e-Pub 2006. PMID: 16980940.
140. * Guo CC, Fine SW, Epstein JI. Noninvasive squamous lesions in the urinary bladder: a clinicopathologic analysis of 29 cases. Am J Surg Pathol 30(7):883-91, 2006. e-Pub 2006. PMID: 16819332.
141. * Guo C, Inghirami G, Ibrahim S, Sen F. Epistaxis and severe weakness in a patient with multiple myeloma: Therapy-related acute myeloid leukemia, pure erythroid leukemia. Arch Pathol Lab Med 130(7):1075-1076, 2006. e-Pub 2006. PMID: 16831041.
142. * Guo C, Armbruster BN, Price DT, Counter CM. In vivo regulation of hTERT expression and telomerase activity by androgen. J Urol 170(2 Pt 1):615-618, 2003. e-Pub 2003. PMID: 12853842.
143. Banik SS, Guo C, Smith AC, Margolis SS, Richardson DA, Tirado CA, Counter CM. C-terminal regions of the human telomerase catalytic subunit essential or in vivo enzyme activity. Mol Cell Biol 22(17):6234-6246, 2002. e-Pub 2002. PMID: 12167716.
144. Armbruster BN, R Banik SS, Guo C, Smith AC, M Counter AC. N-Terminal Domains of the Human Telomerase Catalytic Subunit Required for Enzyme Activity in Vivo. Mol Cell Biol 21(22):7775-7786, 2001. e-Pub 2001.
145. * Guo C, Geverd D, Liao R, Hamad N, Counter CM, Price DT. Inhibition of telomerase is related to the lifespan and tumorigenicity of human prostate cancer cells. J Urol 166(2):694-698, 2001. e-Pub 2001. PMID: 11458119.
146. Rich JN, Guo C, McLendon RE, Bigner DD, Wang XF, Counter CM. A genetically tractable model of human glioma formation. Cancer Res 61(9):3556-3560, 2001. e-Pub 2001. PMID: 11325817.
147. * Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K. A potential role of nuclear matrix associated protein kinase CK2 in protection agains drug-induced apoptosis in cancer cells. J Biol Chem 276(8):5992-5999, 2001. e-Pub 2001. PMID: 11069898.
148. * Guo C, Luttrell LM, Price DT. Mitogenic signaling in androgen sensitive and insensitive prostate cancer cell lines. J Urol 163(3):1027-1032, 2000. e-Pub 2000. PMID: 10688043.
149. Price DT, Della Rocca G, Guo C, Ballo MS, Schwinn DA, Luttrell LM. Activation of extracellular signal-regulated kinase in human prostate cancer. J Urol 162(4):1537-42, 1999. e-Pub 1999. PMID: 10492251.
150. Yu S, Davis AT, Guo C, Green JE, Ahmed K. Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits. J Cell Biochem 74(1):127-134, 1999. e-Pub 1999. PMID: 10381269.
151. * Guo C, Yu S, Davis AT, Ahmed K. Nuclear matrix targeting of the protein kinase CK2 signal as a common downstream response to androgen or growth factor stimulation of prostate cancer cells. Cancer Res 59(5):1146-51, 1999. e-Pub 1999. PMID: 10070976.
152. * Guo C, Davis AT, Yu S, Tawfic S, Ahmed K. Role of protein kinase CK2 in phosphorylation nucleosomal proteins in relation to transcriptional activity. Mol Cell Biochem 191(1-2):135-42, 1999. e-Pub 1999. PMID: 10094402.
153. * Guo C, Davis AT, Ahmed K. Dynamics of protein kinase CK2 association with nucleosomes in relation to transcriptional activity. J Biol Chem 273(22):13675-13680, 1998. e-Pub 1998. PMID: 9593708.
154. Awara WM, Guo C, Conn PM. Effects of Asn318 and Asp87Asn318 mutations on signal transduction by the gonadotropin-releasing hormone receptor and receptor regulation. Endocrinol 137(2):655-662, 1996. e-Pub 1996. PMID: 8593815.
155. * Guo C, Janovick JA, Kuphal DA, Conn PM. Transient transfection of GGH3-1' cells with the carboxyl terminal of beta-adrenergic receptor kinase 1 blocks PRL release: Evidence for a role of the G protein beta gamma-subunit complex in GnRH signal transduction. Endocrinol 136(7):3031-3036, 1995. e-Pub 1995.
156. Xu RK, Zhou YZ, Huang MY, Shan HM, Wang Y, Guo C, Han XS. Regulatory action of galanin on the release of prolactin and beta-endorphin from anterior pituitary of the rat. Chinese J Physiol Sci 12:57-63, 1995. e-Pub 1995.
157. Zhou YZ, Huang MY, Shan HM, Guo C, Han XS, Xu RK. Effect of Cholecystokinin on prolactin release and its action mechanism in the rats. ACTA Acad Med Sinica 17:412-417, 1995. e-Pub 1995.
158. Xu RK, Guo C, Huang MY, Han XS, Zhou YZ, Shan HM, Huang XY. The induction of rat prolactinoma by beta-estradiol and its relaion ot the expression of oncogene c-myc. Dev Reprod Biol 4(1):64-69, 1995. e-Pub 1995.
159. Xu RK, Zhou YZ, Huang MY, Shan HM, Wang Y, Guo C, Han XS. Regulatory role of galanin on prolactin and beta-endorphin release from anterior pituitary lobe of rat. ACTA Physiol Sinica 47:65-72, 1995. e-Pub 1995.
160. * Guo C, Xu RK, Huang MY, Han XS, Zhou YZ, Shan HM. The expression of prolactin gene in the rat prolactinoma induced by estradiol. Basic Med Clinics 13:425-429, 1993. e-Pub 1993.
161. Xu RK, Huang MY, Han XS, Guo C, Zhou YZ, Huang XY. Pancreatic polypeptide in the control of beta-endorphin and prlactin release from rat anterior pituitary in vivo and in vitro. ACTA Physiol Sinica 45(3):215-222, 1993. e-Pub 1993.
162. Xu RK, Guo C, Huang MY, Han XS, Zhou YZ, Shan HM, Huang XY. The induction of rat prolactinoma by beta-estradiol and its relation to the expression of oncogene c-myc. Basic Med Clinics 13:189-192, 1993. e-Pub 1993.
163. Xu RK, Han XS, Huang MY, Shan HM, Zhou YZ, Guo C, Huang XY. Vasoactive intestinal polypeptide in the control of prolactin and beta-endorphin release and its mechanism. Basic Med Clinics 12:353-359, 1992. e-Pub 1992.
164. Han XS, Xu RK, Huang MY, Shan HM, Zhou YZ, Guo C, Huang XY. Effect of angiotensin II prolactin and beta-endorphin release in male rats. Basic Med Clinics 12:360-365, 1992. e-Pub 1992.
165. * Guo C, Zuo J, Fang FD, Xu RK. Simultaneous isolation of high molecular weight RNA and DNA. Basic Med Clinics 12:125-128, 1992. e-Pub 1992.

Invited Articles

1. Guo CC, Czerniak B. Bladder Cancer in the Genomic Era. Arch Pathol Lab Med 143(6):695-704, 2019. e-Pub 2019. PMID: 30672335.

Review Articles

1. Li R, Hensley PJ, Gupta S, Al-Ahmadie H, Babjuk M, Black PC, Brausi M, Bree KK, Fernandez MI, Guo CC, Horowitz A, Lamm DL, Lerner SP, Lotan Y, Mariappan P, McConkey D, Mertens LS, Mir C, Ross JS, O'Donnell M, Palou J, Pohar K, Steinberg G, Soloway M, Spiess PE, Svatek RS, Tan WS, Taoka R, Buckley R, Kamat AM. Bladder-sparing Therapy for Bacillus Calmette-Guerin-unresponsive Non-muscle-invasive Bladder Cancer: International Bladder Cancer Group Recommendations for Optimal Sequencing and Patient Selection. Eur Urol 86(6):516-527, 2024. e-Pub 2024. PMID: 39183090.
2. Riddle, ND, Parkash, V, Guo, CC, Shen, SS, Perincheri, S, Ramirez, AS, Auerbach, A, Belchis, D, Humphrey, PA. Recent Advances in Genitourinary Tumors Updates From the 5th Edition of the World Health Organization Blue Book Series. Archives of Pathology and Laboratory Medicine 148(8):952-964, 2024. e-Pub 2024. PMID: 38031818.
3. Guo, CC, Lee, S, Lee, JG, Chen, H, Zaleski, M, Choi, W, McConkey, DJ, Wei, P, Czerniak, BA. Molecular profile of bladder cancer progression to clinically aggressive subtypes. Nature Reviews Urology 21(7):391-405, 2024. e-Pub 2024. PMID: 38321289.
4. Zhao, J, Guo, CC, Rao, P. Contemporary Issues in Urothelial Carcinoma of Upper Urinary Tract. Advances in anatomic pathology 31(2):80-87, 2024. e-Pub 2024. PMID: 38009077.
5. Fan, J, Guan, Y, Guo, CC, Wang, G. Testicular Germ Cell Tumors with Somatic-type Malignancy. Journal of Clinical and Translational Pathology 3(1):35-42, 2023. e-Pub 2023.
6. Guo, CC, Czerniak, BA. Updates of Prostate Cancer from the 2022 World Health Organization Classification of the Urinary and Male Genital Tumors. Journal of Clinical and Translational Pathology 3(1):26-34, 2023. e-Pub 2023.
7. Guo CC, Czerniak B. Reprint of: somatic-type malignancies in testicular germ cell tumors. Hum Pathol 133:102-114, 2023. e-Pub 2023. PMID: 36890027.
8. Guo, CC, Shen, SS, Czerniak, BA. Recent Advances in the Classification of Bladder Cancer - Updates from the 5th Edition of the World Health Organization Classification of the Urinary and Male Genital Tumors. Bladder Cancer 9(1):1-14, 2023. e-Pub 2023. PMID: 38994481.
9. Guo CC, Czerniak B. Molecular Taxonomy and Immune Checkpoint Therapy in Bladder Cancer. Surg Pathol Clin 15(4):681-694, 2022. e-Pub 2022. PMID: 36344183.
10. Guo CC, Al-Ahmadie HA, Flaig TW, Kamat AM. Contribution of Bladder Cancer Pathology Assessment in Planning Clinical Trials. Urol Oncol 39(10):713-719, 2021. e-Pub 2021. PMID: 29395955.
11. Lobo N, Shariat SF, Guo CC, Fernandez MI, Kassouf W, Choudhury A, Gao J, Williams SB, Galsky MD, Taylor JA, Roupret M, Kamat AM. What Is the Significance of Variant Histology in Urothelial Carcinoma?. Eur Urol Focus 6(4):653-663, 2020. e-Pub 2020. PMID: 31530497.
12. Redrow GP, Guo CC, Brausi MA, Coleman JA, Fernandez MI, Kassouf W, Keeley FX, Margulis V, Raman JD, Roupret M, Shariat SF, Spiess PE, Thalmann GN, Matin SF. Upper Urinary Tract Carcinoma in Situ: Current Knowledge, Future Direction. J Urol 197(2):287-295, 2017. e-Pub 2017. PMID: 27664578.
13. Kamat AM, Hahn NM, Efstathiou JA, Lerner SP, Malmström PU, Choi W, Guo CC, Lotan Y, Kassouf W. Bladder cancer. Lancet 388(10061):2796-2810, 2016. e-Pub 2016. PMID: 27345655.
14. * Dadhania V, Czerniak B, Guo CC. Adenocarcinoma of the urinary bladder. Am J Clin Exp Urol 3(2):51-63, 2015. e-Pub 2015. PMID: 26309895.
15. Bilen MA, Hariri H, Leon C, Guo CC, Kuban DA, Pisters LL, Tu SM. Positive FDG-PET/CT Scans of a Residual Seminoma after Chemotherapy and Radiotherapy: Case Report and Review of the Literature. Clin Genitourin Cancer 12(4):147-150, 2014. e-Pub 2014. PMID: 24674785.
16. Dayyani F, Hoffman K, Eifel P, Guo CC, Vikram R, Pagliaro LC, Pettaway C. Management of advanced primary urethral carcinomas. BJU Int 114(1):25-31, 2014. e-Pub 2014. PMID: 24447439.

Professional Educational Materials

1. Harik LR, Paner GP Al-Ahmadie HA, Allan RW, Amin MB, Bilen MA, Bochner BH, Guo CC, Lopez-Beltran A, McKenney, JK, Sangoi AR, Sirintrapun SJ, Wadia R, Wobker SE, Zhou, M. Protocol for the Examination of Cystectomy Specimens From Patients With Carcinoma of the Urinary Bladder. College of American Pathologists, 2023.
2. Harik LR, Paner GP Al-Ahmadie HA, Allan RW, Amin MB, Bilen MA, Bochner BH, Guo CC, Lopez-Beltran A, McKenney, JK, Sangoi AR, Sirintrapun SJ, Wadia R, Wobker SE, Zhou, M. Protocol for the Examination of Biopsy and Transurethral Resection of Bladder Tumor (TURBT) Specimens From Patients With Carcinoma of the Urinary Bladder. College of American Pathologists, 2023.

Other Articles

1. Bondaruk, J, Jaksik, R, Wang, Z, Cogdell, D, Lee, S, Chen, Y, Dinh, KN, Majewski, T, Zhang, L, Cao, S, Tian, F, Yao, H, Kuś, P, Chen, H, Weinstein, JN, Navai, N, Dinney, CP, Gao, J, Theodorescu, D, Logothetis, CJ, Guo, CC, Wang, W, McConkey, DJ, Wei, P, Kimmel, M, Czerniak, BA Erratum. iScience 25(7), 2022. PMID: 35811851.

Editorials

1. Guo CC, Shen SS, Ro JY. Pathogenesis and Diagnosis of Genitourinary Cancer. Cancers (Basel) 13(2):347, 2021. PMID: 33477810.
2. Guo CC, Ro JY. The 58th Annual Symposium of the Houston Society of Clinical Pathologists. Arch Pathol Lab Med 143(5):548-9, 2019. PMID: 31026219.

Abstracts

1. Clemente LC, Zhang J, Parra E, Tamegnon A, Ibarguen H, Khan K, Pandurengan R, Zhang S, Kumar G, Haymaker C, Guo C, Wistuba I, Matin S. A Suppressive Tumor Microenvironment Is Associated with Higher Cancer Stage and Worse Outcome in Treatment-Naive Upper Tract Urothelial Carcinoma. Laboratory Investigation 104(S3):S912-S914, 2024. e-Pub 2024.
2. Shen Y, Zheng L, Zhao J, Wang Y, Wei P, Chen H, Roy-Chowdhuri S, Hansel D, Czerniak B, Guo CC. Molecular Profile of Micropapillary Urothelial Carcinoma of the Urinary Bladder: An Analysis of 99 Cases by Next Generation Sequencing. Laboratory Investigation 104(S3):S1054-S1055, 2024. e-Pub 2024.
3. Zhang Q, Zheng L, Chen H, Roy-Chowdhuri S, Hansel D, Czerniak B, Guo CC. Mutational Profile of Small Cell Carcinoma of the Urinary Bladder. Laboratory Investigation 104(S3):S1088-S1089, 2024. e-Pub 2024.
4. Zheng L, Guo C, Tabet G, Rizvi Y, Raso MG, Liu J, Ding Q, Baraban E, Zhao J. Differential Expression of SOX17 in Clear Cell Adenocarcinoma of the Genitourinary and Gynecologic Tracts. Laboratory Investigation 104(S3):S891-2, 2024. e-Pub 2024.
5. Czerniak B, Lee S, Jaksik R, Kus P, Wang Z, Lee JG, Navai N, Dinney C, McConkey D, Guo CC, Wang W, Wei P, Kimmel M. Dysregulation of Mucosal Microenvironment Drives the Progression of Urothelial Field Effects to Invasive Bladder Cancer. Laboratory Investigation 104(S3):S925, 2024. e-Pub 2024.
6. Hosseini H, Kokabee M, Czerniak B, Guo CC. Choriocarcinoma of the Testis: A Clinicopathological Study of 123 Cases. Laboratory Investigation 104(S3):S963-S964, 2024. e-Pub 2024.
7. Tabet G, Zheng L, Hosseini H, Czerniak B, Guo CC. Testicular Epithelioid Trophoblastic Tumor – A Report of Five Cases. Laboratory Investigation 104(S3):S1060, 2024. e-Pub 2024.
8. Al-Attar M, Elzamly S, Zhang Q, Zheng L, Chen H, Roy-Chowdhuri S, Hansel D, Czerniak B, Guo C. Mutational Profile of Sarcomatoid Urothelial Carcinoma. Mod Pathol 104(3):S898-S899, 2024. e-Pub 2024.
9. Czerniak B, Lee S, Jung S, Kus P, Jaksik R, Lee JG, Chen H, Navai N, Guo CC, Wei P, Kimmel M. Modeling of Bladder Cancer Evolution from Whole-Organ Mutational and Proteomic Profiles. Laboratory Investigation 103(S3):S704, 2023. e-Pub 2023.
10. Zhao J, Czerniak B, Guo CC. Diagnostic Discordance of Upper Urinary Tract Urothelial Carcinoma between Biopsy and Nephroureterectomy Specimens: A Tertiary Cancer Center Experience. Laboratory Investigation 103(S3):S838, 2023. e-Pub 2023.
11. Zheng L, Chen H, Zhao J, Czerniak B, Roy-Chowdhuri S, Guo CC. Mutational Landscape of Plasmacytoid Urothelial Carcinoma of the Urinary Bladder: An Analysis of 51 cases by Next Generation Sequencing. Laboratory Investigation 103(S3):S839, 2023. e-Pub 2023.
12. Rohra P, Shehabeldin A, Ebare K, Nair V, Zhao J, Czerniak B, Guo CC. Gene Mutations in Urothelial Carcinoma of the Upper Urinary Tract: An Analysis of 55 Cases by Next-Generation Sequencing. Laboratory Investigation 103(S3):S795, 2023. e-Pub 2023.
13. Shehabeldin A, Guo CC, Ebare K, Czerniak B, Hensley P. Gene Mutations in Urothelial Carcinoma of the Upper Urinary Tract. Modern Pathology 35(S2), 2022. e-Pub 2022.
14. Hotchandani N, Czerniak B, Guo CC. Clear Cell Adenocarcinoma of the Genitourinary Tract: A Clinicopathologic Study of 31 Cases. Modern Pathology 35(S2):599, 2022. e-Pub 2022.
15. Zaleski M, Wang Z, Bondaruk J, Cogdell D, Lee S, Kimmel M, Wei P, Guo CC, Czerniak B. Immune Landscape of Bladder Cancer and Its Aggressive Highly Lethal Variants. Modern Pathology 34(S2):635, 2021. e-Pub 2021.
16. Zaleski M, Chen H, Czerniak B, Guo CC. Next-Generation Sequencing Analyses of Gene Mutations in Urachal Carcinoma. Modern Pathology 34(S2):530, 2021. e-Pub 2021.
17. Hwang M, Hamza A, Czerniak B, Guo CC. Somatic-Type Malignancy in Testicular Germ Cell Tumor - A Clinicopathologic Analysis of 53 Cases. Mod Pathol 33:901-2, 2020. e-Pub 2020.
18. Czerniak B, Yang G, Bondaruk J, Wang Z, Wei P, Cogdell D, Yao H, Guo CC. Genomic Characterization of Small Cell Bladder Cancer. Mod Pathol 33:879, 2020. e-Pub 2020.
19. Hamza A, Hwang MJ, Czerniak B, Guo CC. Secondary Tumors of the Bladder: A Report of 84 cases. Mod Pathol 33:893-4, 2020. e-Pub 2020.
20. Guo CC, Majewski T, Czerniak B. Genome-Wide Characterization of Sarcomatoid Bladder Cancer. Mod Pathol 32(S2):61, 2019. e-Pub 2019.
21. Hwang MJ, Czerniak B, Guo CC. Clinicopathologic Analysis of Bladder Cancer Involving Muscularis Mucosae or Smooth Muscle of an Indeterminate Type on Transurethral Resection Specimens. Mod Pathol 32(S2):71, 2019. e-Pub 2019.
22. Guo CC, Majewski T, Dinney C, Czerniak B. Useful Immunohistochemical Markers in the Molecular Classification of Bladder Cancer. Mod Pathol 32(S2):60-61, 2019. e-Pub 2019.
23. Guo CC, Majewski T, Zhang L, Bondaruk J, Kamat A, Dinney C, McConkey D, Czerniak B. Progression to Sarcomatoid Bladder Cancer is Associated with Dysregulation of Chromatin Remodeling and Cell Cycle Circuits. Mod Pathol 31(S2):346, 2018. e-Pub 2018.
24. Majewski T, Bondaruk J, Yao H, Lee S, Lee J, Zhang L, Guo CC, Dinney C, McConkey D, Baggerly K, Czerniak B. Genomic Profile of Field Effects and Their Progression to Clinically Evident Bladder Cancer. Mod Pathol 31(S2):363, 2018. e-Pub 2018.
25. Hruska CJ, Czerniak B, Guo CC. Paraganglioma of the Urinary Bladder: A Pathologic and Clinical Study of 26 Cases. Mod Pathol 30(S2):231A, 2017. e-Pub 2017.
26. Wang G, Xiao L, Zhang M, Czerniak B, Guo CC. Small Cell Carcinoma of the Urinary Bladder: A Clinicopathologic Analysis of 81 Cases. Mod Pathol 30(S2):266A, 2017. e-Pub 2017.
27. Dadhania V, Zhang M, Zhang L, Bondaruk J, Majewski T, Siefker-Radtke A, Guo CC, Dinney C, Cogdell DE, Zhang S, Lee S, Lee JG, Weinstein JN, Baggerly K, McConkey D, Czerniak B. Molecular Characterization of Luminal and Basal Subtypes of Bladder Cancer. Mod Pathol 30(S2):219A, 2017. e-Pub 2017.
28. Rao P, Naovarat B, Guo CC, Sircar K, Zhang M, Khalil F, Hernandez M, Tamboli P, Pettaway CA, Spiess PE, Dhillon J. Inter-Observer Variability among Urologic Pathologists in the Grading of Penile Squamous Cell Carcinoma. Mod Pathol 29(S2):257A, 2016. e-Pub 2016.
29. Dadhania V, Guo CC, Zhang M, Majewski T, Zhang L, Bondaruk J, Zhang S, Choi W, McConkey D, Dinney C, Baggerly K, Czerniak B. Molecular Subtypes of Bladder Cancer and Their Signature Markers in Multi-Institutional Cohorts. Mod Pathol 29(S2):224A, 2016. e-Pub 2016.
30. Gilani S, Czerniak BA, Guo CC. Urothelial Carcinoma of the Upper Urinary Tract: A Clinicopathologic Study of 100 Cases. Mod Pathol 29(S2):232A, 2016. e-Pub 2016.
31. Guo CC, Dadhania V, Zhang L, Bondaruk J, Majewski T, Sykulski M, Wronowska W, Gambin A, Kamat A, Dinney C, Choi W, McConkey D, Weinstein J, Czerniak B. Molecular Characterization of Clinically Aggressive Micropapillary Bladder Cancer. Mod Pathol 29(S2):235A, 2016. e-Pub 2016.
32. Zhang M, Guo CC, Majewski T, Dadhania V, Skyulski M, Wronowska W, Choi W, McConkey D, Dinney C, Gambin A, Czerniak B. Immunohistochemical Profiles of Molecular Subtypes of Bladder Cancer. Mod Pathol 28(S2):270A, 2015. e-Pub 2015.
33. Huang H, Xiao L, Zhang M, Czerniak B, Guo CC. Sarcomatoid Carcinoma of the Urinary Bladder: A Clinicopathological Analysis of 73 Cases. Mod Pathol 28(S2):229A, 2015. e-Pub 2015.
34. Guo CC, Majewske T, Dadhania V, Willis D, Sykulski M, Wronowska W, Kamat A, Choi W, McConkey D, Dinney C, Gamblin A, Czerniak B. Gene Expression Profile of Micropapillary Bladder Cancer. Mod Pathol 28(S2):225A, 2015. e-Pub 2015.
35. Liang Y, Wani K, Wang Y, Czerniak B, Guo CC. Distinct Expression of MicroRNAs in Micropapillary Variant of Urothelial Carcinoma. Mod Pathol 28(S2):239A, 2015. e-Pub 2015.
36. Fox M, Xiao L, Czerniak B, Guo CC. Plasmacytoid Variant of Urothelial Carcinoma: A Clinocopathological Study of 49 Cases. Mod Pathol 28(S2):221A, 2015. e-Pub 2015.
37. Li W, Liang Y, Deavers MT, Czerniak B, Guo CC. Uroplakin II is more sensitive than uroplakin III in urothelial carcinoma and its variants. Mod Pathol 27(S2):244A, 2014. e-Pub 2014.
38. Liang Y, Heitzman J, Czerniak B, Guo CC. Differential Expression of GATA-3 in Urothelial Carcinoma Variants. Mod Pathol 27(S2):244A, 2014. e-Pub 2014.
39. Heitzman J, Czerniak B, Guo CC. Using Cytokeratin Expression Pattern to Evaluate Differentiation in Urothelial Carcinoma of the Upper Urinary Tract. Mod Pathol 26(S2):217A, 2013. e-Pub 2013.
40. Murugan P, Tamboli P, Czerniak B, Guo CC. Ewing Sarcoma/Primitive Neuroectodermal Tumor of the Kidney: A Clinicopathologic Study of 23 Cases. Mod Pathol 26(S2):237A, 2013. e-Pub 2013.
41. Henderson SA, Heitzman JP, Czerniak B, Guo CC. Microsatellite Instability in Urothelial Carcinoma of the Upper Urinary Tract. Mod Pathol 26(S2):217A, 2013. e-Pub 2013.
42. Rao P, Czerniak BA, Guo CC. Primary Clear Cell Adenocarcinoma of the Urethra: A Clinicopathologic Study of 16 Cases. Mod Pathol 25(2S):236A, 2012. e-Pub 2012.
43. Guo CC, Mikulasovich MP, Deavers MT, Troncoso P, Czerniak BA. ERG Protein Expression and ERG Gene Rearrangement in Prostate Cancers of Different Zonal Origins. Mod Pathol 25(2S):210A, 2012. e-Pub 2012.
44. Mikulasovich MP, Stanton ML, Guo CC, Deavers MT, Troncoso P, Prokhorova IN, Czerniak BA, Troncoso P. TMPRSS2-ERG Gene Fusion in Prostate Cancer of Central Zone Origin. Mod Pathol 25(2S):227A, 2012. e-Pub 2012.
45. Tarrant WP, Czerniak BA, Guo CC. Pathological Analysis of Testicular Germ Cell Tumor with Metastasis in Retroperitoneal Lymph Nodes. Mod Pathol 25(2S):244A, 2012. e-Pub 2012.
46. Lee S, Lee SK, Bondaruk J, Majewski T, Wang H, Zhang S, Bar-Eli M, Black P, Wang Y, Guo CC, Dinney D, Grossman HB, Knowles M, Baggerly K, Czerniak B. Ras Pathway Activated by Loss of ARL11: A Missing Link in Cancer Initiation. Mod Pathol 24(1S):224A, 2011. e-Pub 2011.
47. Shen SS, Guo CC, Ro JY, Anton R, Cheng L, Hameed O, Truong LD, Huang J, Weiss MA, Lin F, Srigley JR, McKenney JK, Tamboli P, Grignon DJ, Jimenez RE, Zhou M, Paner GP, Troncoso P, Amin MB, Ayala AG. Common Diagnostic Problems in Interpretation of Early Invasive Bladder Cancer: A Consensus Study. Mod Pathol 24(1S):224A, 2011. e-Pub 2011.
48. Dhillon J, Czerniak B, Guo CC. Urachal Carcinoma: A Clinicopathologic Study of 46 Cases. Mod Pathol 24(1S):188A, 2011. e-Pub 2011.
49. Si Q, Xiao L, Bondaruk Y, Wang Y, Czerniak B, Guo CC. Enrichment of Cancer Stem Cells in Urothelial Carcinoma and Small Cell Carcinoma of the Urinary Bladder. Mod Pathol 24(1S):207A, 2011. e-Pub 2011.
50. Lee S, Lee SK, Zhang S, Bondaruk J, Majewski T, Chung W, Xiao L, Guo CC, Issa JP, Bar-Eli M, Baggerly K, Czerniak B. Field Change in Bladder Carcinogenesis: The Concept of Forerunner Genes. Mod Pathol 23(1S):388A, 2010. e-Pub 2010.
51. Xiao L, Gong Y, Wang Y, Troncoso P, Czerniak BA, Guo CC. The TMPRSS2-ERG Gene Fusion in Small Cell Carcinoma of the Prostate. Mod Pathol 23(1S):229A, 2010. e-Pub 2010.
52. Wang P, Allan RW, Guo CC, Peng Y, Humphrey PA, Li J, Cao D. UTF-1 Is a Novel Diagnostic Marker for Testicular Embryonal Carcinoma and Seminoma. Mod Pathol 23(1S):227A, 2010. e-Pub 2010.
53. Stanton ML, Xiao L, Czerniak BA, Guo CC. Urothelial Tumors in Patients under the Age of 30 Years: A Report of 58 Cases. Mod Pathol 23(1S):221A, 2010. e-Pub 2010.
54. Lee TK, Miyamoto H, Osunkoya AO, Guo CC, Weiss SW, Epstein JI. Smooth Muscle Neoplasms of the Urinary Bladder: A Clinicopathological Study of 51 Cases. Mod Pathol 23(1S):202A, 2010. e-Pub 2010.
55. Stanton M, Guo CC, Li X, Wang Y, Andino L, Prokhorova IN, Pisters LL, Troncoso P. TMPRSS2-ERG Gene Fusion Status in Salvage Radical Prostatectomy Specimens Following Radiotherapy. Mod Pathol 23(1S):221A, 2010. e-Pub 2010.
56. Cao D, Allan RW, Guo CC, Peng Y, Li J. Overexpression of TCL1 in Testicular Germ Cell Tumors. Mod Pathol 23(1S):182A, 2010. e-Pub 2010.
57. Guo CC, Wang Y, Xiao L, Prokhorova I, Troncoso P, Czerniak BA. The Relationship of TMPRSS2-ERG Gene Fusion between Primary and Metastatic Prostate Cancers. Mod Pathol 23(1S):193A, 2010. e-Pub 2010.
58. Si Q, Stanton M, Tamboli P, Czerniak BA, Guo CC. Primary Small Cell Carcinoma of the Renal Pelvis: A Report of 11 Cases. Mod Pathol 23(1S):219A, 2010. e-Pub 2010.
59. Miller JS, Zhou M, Brimo F, Guo CC, Epstein JI. Primary Leiomyosarcoma of the Kidney: A Clinicopathologic Study of 27 Cases. Mod Pathol 23(1S):219A, 2010. e-Pub 2010.
60. Andino L, Guo CC, Chiong E, Prokhorova IN, Pisters LL, Troncoso P. Pathologic Features of Salvage Radical Prostatectomy Specimens Following Radiotherapy: Implications for Focal Therapeutic Options. Mod Pathol 22(1S):157A, 2009. e-Pub 2009.
61. Trock B, Guo CC, Epstein JI. Biochemical recurrence related to teriary Gleason patterns at radical prostatectomy. Mod Pathol 22(1S):198A, 2009. e-Pub 2009.
62. Dancer JY, Zuo G, Soto C, Troncoso P, Czerniak B, Guo CC. TMPRSS2-ERG Gene Fusion in Small Cell Carcinoma of the Prostate. Mod Pathol 22(1S):164A, 2009. e-Pub 2009.
63. Liang M, Troncoso P, Czerniak B, Guo CC. Rhabdomyosarcoma of the Urinary Bladder and Prostate in Adults: A Clinicopathologic Study of 11 Cases. Mod Pathol 22(1S):178A, 2009. e-Pub 2009.
64. Guo CC, Zuo G, Cao D, Troncoso P, Czerniak B. Prostate Cancer of Transition Zone Origin Lacks TMPRSS2-ERG Gene Fusion. Mod Pathol 22(1S):171A, 2009. e-Pub 2009.
65. Guo CC, Pisters LL, Troncoso P. Involvement of the rectum by prostatic adenocarcinoma in total pelvic exenteration speciemens. Mod Pathol 21(1S):159A, 2008. e-Pub 2008.
66. Guo CC, Cao D, Navone N, Efstathiou E, Maity S, Troncoso P, Czerniak, B. TMPRSS2-ERG gene fusion in metastatic prostate cancer. Histopathology 53(1S):277, 2008. e-Pub 2008.
67. Gomez EM, Tamboli P, Czerniak BA, Guo CC. Non-Bilharzial squamous cell carcinoma of the urinary bladder: A clinicopathological study of 16 cases. Mod Pathol 21(1S):158A, 2008. e-Pub 2008.
68. Punar M, Guo CC, Tamboli P, Czerniak BA. Somatic transformation to sarcoma in testicular germ cell tumors: A clinicopathologic analysis of 33 cases. Mod Pathol 21(1S):177A, 2008. e-Pub 2008.
69. Zhou Z, Sotelo EP, Tamboli P, Czerniak BA, Guo CC. Choriocarcinoma in the testis: A clinicopathological study of 65 cases. Mod Pathol 21(1S):194A, 2008. e-Pub 2008.
70. Wang W, Guo CC, Hansel D, Shen R, Ali T, Epstein JI. Testicular carcinoid tumor: A study on 13 cases. Mod Pathol 21(1S):188A, 2008. e-Pub 2008.
71. Luina-Contreras A, Tamboli P, Czerniak BA, Guo CC. Primay Mediastinal Germ Cell Tumors with Somatic Transformation to Angiosarcoma: A Report of 9 Cases. Mod Pathol 21(1S):346A, 2008. e-Pub 2008.
72. Guo CC, Nielson ME, Epstein JI. Large cell undifferentiated carcinoma in the urinary bladder: A clinicopathological study of 33 cases. Mod Pathol 20(2S):150A, 2007. e-Pub 2007.
73. Guo CC, Tamas EF, Trock BJ, Epstein JI. Prognostic significance of positive surgical margins in radical prostatectomies: An analysis basedon their anatomic locations. Mod Pathol 20(2S):150A, 2007. e-Pub 2007.
74. Guo CC, Epstein JI. Intraductal carcinoma of the prostate: Histologic features and clinical significance. Mod Pathol 19(1S):139A, 2006. e-Pub 2006.
75. Guo CC, Epstein JI. Prognostic significance of non-invasive squamous lesions in urinary bladder. Mod Pathol 19(1S):140A, 2006. e-Pub 2006.
76. Guo C, Zhang X, Chiriboga L, Yee H, Melamed J, Lee P. Decreased expression of PRMT5 is associated with prostate cancer. Mod Pathol 18(1S):143A, 2005. e-Pub 2005.
77. Guo C, Kong X, Lee P, Melamed J. Expressed of mucin antigens in renal tumors. Mod Pahtol 18(1S):143A, 2005. e-Pub 2005.
78. Guo C, Wang GH, Yang GU, Chiriboga L, Yee H, Melamed J. Attenuated expression of Wisp-1 in renal tumors. Mod Pathol 17(1S):647, 2004. e-Pub 2004.
79. Guo C, Yang GY, Kuhn K, Kong X, Lee P, Melamed J. Differential activation of Stat-3 in renal tumors. Mod Pathol 17(1S):648, 2004. e-Pub 2004.
80. Clemente L, Zhang J, Parra E, Tamegnon A, Ibarguen H, Khan K, Pandurengan R, Zhang S, Kumar G, Haymaker C, Guo C, Wistuba I, Matin S. A Suppressive Tumor Microenvironment Is Associated with Higher Cancer Stage and Worse Outcome in Treatment-Naive Upper Tract Urothelial Carcinoma. Mod Pathol 104(3):S912-S914, 2004. e-Pub 2004.
81. Guo C, Yu S, Davis AT, Wang H, Green JE, Ahmed K. A potential role of nuclear matrix associated protein kinase CK2 in protection against drug-induced apoptosis in cancer cells. The 40th Annual Meeting of American Society for Cell Biology, 2000. e-Pub 2000.
82. Guo C, Geverd D, Counter CM, Price DT. Androgen regulation of telomerase activity and experession in prostate cancer. Southeast Section of American Urological Association, 2000. e-Pub 2000.
83. Guo C, Hamad N, Geverd D, Liao RP, Counter CM, Price DT. Inhibition of telomerase activity using a dominant negative construct of hTERT in prostate cancer cell lines. American Urological Association, 2000. e-Pub 2000.
84. Guo C, Conter CM, Price DT. Androgen regulatio of telomerase activity and expression in prostate cancer. American Urological Association, 2000. e-Pub 2000.
85. Price DT, Pao KF, Guo C, Daaka Y. Survival signaling in androgen independent prostate cancer cells. Surgical Forum, 1999. e-Pub 1999.
86. Price DT, Dell Rocca G, Eckhart AD, Guo C, Ballo MS, Daaka Y, Schwinn DA, Luttrell LM. Increased activation of extracellular signal regulated kinase in human prostate cancer. American Urological Association, 1999. e-Pub 1999.
87. Yu SH, Davis AT, Guo C, Green JE, Ahmed K. Differential targeting of protein kinase CK2 to the nuclear matrix upon transient overexpression of its subunits. The 38th Annual Meeting of American Society of Cell Biology, 1998. e-Pub 1998.
88. Price DT, Dell Rocca G, Eckhart AD, Guo C, Ballo MS, Daaka Y, Schwinn DA, Luttrell LM. Increased activation of extracellular signal regulated kinase in human prostate cancer. AACR Proceeding, Special Meeting on Prostate Cancer Biology, 1998. e-Pub 1998.
89. Guo C, Davis AT, Yu S, Tawfic S, Ahmed K. Role of protein kinase CK2 in phosphorylation of neucleosomal proteins in relation to transcroptional activity. The 1997 Annual Meeting of American Society of Biochemistry and Molecular Biology, 1997. e-Pub 1997.
90. Guo C, Davis AT, Ahmed K. Dynamics of protein kinase CK2 association with nucleosomes in relation to transcriptional activity. The 36th Annual Meeting of American Society for Cell Biology, 1996. e-Pub 1996.
91. Guo C, Janovick JA, Kuphal DA, Conn PM. Transient transfection of GGH3-1' cells with the carboxyl terminal of beta-adrenergic receptor kinase 1 blocks PRL release: Evidence for a role of the G protein beta gamma-subunit complex in GnRH signal transduction. The Annual Endocrine Society Meeting, 1995. e-Pub 1995.

Book Chapters

1. Guo CC. 214. Embryonal Carcinoma. In: Uropathology. 2nd. Elsevier, 477-479, 2022.
2. Guo CC. 260. Epithelial Tumors of the Rete Testis. In: Uropathology. 2nd. Elsevier, 569-570, 2022.
3. Guo CC. 216. Postpubertal-Type Teratoma. In: Uropathology. 2nd. Elsevier, 483-484, 2022.
4. Guo CC. 215. Postpubertal-Type Yolk Sac Tumor. In: Uropathology. 2nd. Elsevier, 480-482, 2022.
5. Guo CC, Aron M, Lopez-Beltran A, Paner G, Reis H. Bladder Adenocarcinoma. In: WHO Classification of Tumours of the Urinary System and Male Genital Organs. 5. WHO Press, 173-176, 2022.
6. Guo CC. 70. Polypoid and Papillary Cystitis. In: Uropathology. 2nd. Elsevier, 166-167, 2022.
7. Guo CC. 98. Urothelial Carcinoma with Squamous Differentiation. In: Uropathology. 2nd. Elsevier, 225, 2022.
8. Guo CC. 248. Adenomatoid Tumor. In: Uropathology. 2nd. Elsevier, 549-550, 2022.
9. Guo CC. 27. Intraductal Carcinoma of the Prostate. In: Uropathology. 2nd. Elsevier, 56-58, 2022.
10. Guo CC. 202. Postpubertal Gonadotrophin Deficiency. In: Uropathology. 2nd. Elsevier, 453, 2022.
11. Guo CC. 293. Mixed Squamous Cell Carcinoma of the Penis. In: Uropathology. 2nd. Elsevier, 629-630, 2022.
12. Guo CC. 189. Testis - Anatomy and Histology. In: Uropathology. 2nd. Elsevier, 428-429, 2022.
13. Guo CC. 218. Teratoma with Somatic-Type Malignancies. In: Uropathology. 2nd. Elsevier, 487-488, 2022.
14. Guo CC. 223. Prepubertal-Type Teratoma - Testicular Carcinoid Tumor. In: Uropathology. 2nd. Elsevier, 496-497, 2022.
15. Guo CC. 240. Testicular Cancer Staging. In: Uropathology. 2nd. Elsevier, 533, 2022.
16. Guo CC. 46. Urothelial Carcinoma of the Prostate. In: Uropathology. 2nd. Elsevier, 105-107, 2022.
17. Guo CC. 213. Seminoma. In: Uropathology. 2nd. Elsevier, 473-476, 2022.
18. Guo CC. 171. Wilms Tumor. In: Uropathology. 2nd. Elsevier, 389--391, 2022.
19. Guo CC. 132. Simple Cortical Cyst in the Kidney. In: Uropathology. 2nd. Elsevier, 299, 2022.
20. Guo CC. 269. Primary Urethral Carcinoma. In: Uropathology. 2nd. Elsevier, 586-587, 2022.
21. Guo CC. 158. Clear Cell Papillary Renal Cell Carcinoma. In: Uropathology. 2nd. Elsevier, 358-359, 2022.
22. Guo CC. 122. Molecular Genomics of Bladder Cancer. In: Uropathology. 2nd. Elsevier, 275-278, 2022.
23. Zhou, HJ, Guo, CC, Ro, JY. Introduction to urinary bladder pathology, 1-5, 2021.
24. Guo, CC, Ro, JY, Czerniak, BA. Invasive urothelial carcinoma with molecular types, 45-61, 2021.
25. Zhou, HJ, Guo, CC, Ro, JY. Conclusion and remarks, 249-252, 2021.
26. Zhou, HJ, Guo, CC, Ro, JY. Papillary and inverted tumors, 35-44, 2021.
27. Guo CC, Ro JY, Czerniak B. Invasive urothelial carcinoma with molecular types. In: Bladder Cancer: Recent Advances in Surgical and Molecular Pathology. 1. Springer, 45-61, 2021.
28. Zynger DL, Guo CC. Testis and Paratesticular Lesions. In: Practical Genitourinary Pathology: Frequently Asked Questions. First. Springer, 187-246, 2021.
29. Zhou HJ, Guo CC, Ro JY. Papillary and Inverted Tumors. In: Urinary Bladder Pathology. 1. Springer, 35-44, 2021.
30. Divatia MK, Guo CC, Rehman A, Ro JY. Major Subtypes of Renal Cell Carcinoma. In: Kidney Cancer: Recent Advances in Surgical and Molecular Pathology. First. Springer, 77-114, 2020.
31. Guo CC, Zhang M, Sircar K. Tumors of the Renal Pelvis. In: Kidney Cancer: Recent Advances in Surgical and Molecular Pathology. First. Springer, 261-281, 2020.
32. Zhang M, Guo CC. Neuroendocrine Kidney Tumors. In: Kidney Cancer: Recent Advances in Surgical and Molecular Pathology. First. Springer, 193-205, 2020.
33. Ulbright T, Amin MB, Balzer B, Berney DM, Epstein JI, Guo CC, Idrees MT, Looijenga LHJ Paner G, Rajpert-De Meyts E, Skakkebaek NE, Tickoo, SK, Yilmaz A, Oosterhuis JW. Germ Cell Tumors. In: The WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th. International Agency for Research on Cancer (IARC), 189-226, 2016.
34. Guo CC. Adenocarcinoma. In: Advances in Surgical Pathology: Bladder Cancer. 1st. Wolters Kluwer, 136-148, 2016.
35. Guo CC, Smith AK, Pavlovich CP. Familial Forms of Renal Cell Carcinoma and Associated Syndromes. In: The Kidney: A Comprehensive Guide to Pathologic Diagnosis and Management. 1. Springer, 81-96, 2015.
36. Guo CC. Neoplasms of the Testis. In: Genitourinary Pathology. 2nd. Elsevier Science, 600-687, 2015.
37. Guo CC. Adenomatoid tumor. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 442-443, 2012.
38. Guo CC. Testicular cancer stage. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 432, 2012.
39. Guo CC. Teratoma. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 397-398, 2012.
40. Guo CC. Clear cell papillary renal cell carcinoma. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 298-299, 2012.
41. Guo CC. Urothelial carcinoma with squamous differentiation. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 190, 2012.
42. Guo CC. Neoplasms of the rete testis. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 430-431, 2012.
43. Guo CC. Simple renal cortical cyst. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 244, 2012.
44. Guo CC. The testitis: normal anatomy and histology. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 350-351, 2012.
45. Guo CC, Moore C. Inflammatory and Infectious diseases. In: The Urinary Tract: A Comprehensive Guide to Patient Diagnosis and Management. First. Springer, 63-79, 2012.
46. Guo CC. Embryonal carcinoma. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 391-393, 2012.
47. Guo CC. Primary urethral carcinoma. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 473, 2012.
48. Guo CC. Seminoma. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 386-389, 2012.
49. Guo CC. Postpubertal gonadotropin deficiency. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 368, 2012.
50. Guo CC. Mixed carcinomas. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 499, 2012.
51. Guo CC. Polyploid and papillary cystitis. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 144-145, 2012.
52. Guo CC. Wilms tumor. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 306-308, 2012.
53. Guo CC. Intraductal carcinoma of the prostate. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 55-56, 2012.
54. Guo CC. Testicular carcinoid tumor. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 403-404, 2012.
55. Guo CC. Teratoma with secondary malignant components. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 401-402, 2012.
56. Guo CC. Yolk sac tumor. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 394-396, 2012.
57. Guo CC. Urothelial carcinoma of the prostate. In: High Yield Pathology: Genitourinary Pathology. First. Elsevier, 92-93, 2012.

Books (edited and written)

1. Zhou HJ, Guo CC, Ro JY. Urinary Bladder Pathology. Ed(s) First. Springer, 2021.
2. Divatia MK, Ozcan A, Guo CC, Ro JY. Kidney Cancer: Recent Advances in Surgical and Molecular Pathology. Ed(s) First. Springer, 2020.

Letters to the Editor

1. Guo CC, Shen SS, Si Q, Dancer J, Stanton ML, Tamboli P, Ro JY, Czerniak BA. Necrosis assessment in renal carcinoma-reply. Hum Pathol 43: 151-2, 2012.
2. Guo CC, Troncoso P, Wang Y, Xiao L, Czerniak B. TMPRSS2-ERG gene fusion in transition zone prostate cancer. Modern Pathology 23: 1041-1042, 2010.

Patents

1. Gao JJ, Logothetis C, Chen J, Alhalabi O, Wang L, Titus M, Czerniak B, Guo CC, Wang WL, Zhang M, Campbell M, Shah A. Combination therapy with anti-folate agents and MTAP receptor antagonists for MTAP-deficient tumors. Patent Number: USA MDA 17-129.